Governments

 ! This page contains references to documents produced by governments of all countries or international bodies. For this reason, it may be too general to do a useful search ! 

And it takes long to charge ...

 

 
Title Link
OECD - Conference on New Biotechnology Food and Crops, Science, Safety and Society - Bangkok, Thailand, July 10-12, 2001.- (29 pages) http://www1.oecd.org/bangkok/bangkokfinalreport.PDF
OECD - Report of the OECD workshop on the toxicological and nutritional testing of novel foods -Meeting of the Ad Hoc Expert Group on Food Safety - (48 pages) http://www1.oecd.org/ehs/ehsmono/aussoidrEN.pdf
OECD - Safety Assessments of new foods - results of an OECD Survey of Serum Banks for Allergenicity testing, and use of databases - Internal co-ordination group for biotechnology - February 1997 - (34 pages) http://www1.oecd.org/ehs/ehsmono/surveydrEN.pdf
OECD - Carliene Brenner - Intellectual property rights and technology transfer in developing country agriculture: rhetoric and reality - Technical paper 133 - March 1998 - (51 pages) http://www1.oecd.org/dev/PUBLICATION/tp/Tp133.pdf
FDA - CDER - subscribe to mailing lists free of charge. http://www.fda.gov/cder/cdernew/listserv.html
FDA -(proposed) Pediatric Rule - Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients - 21 CFR Parts 201, 312, 314, and 601 - (99 pages) http://www.fda.gov/cder/guidance/pedrule.pdf
US. District Court for the District of Columbia - Memorandum and opinion -October 25, 2001 - (24 pages) http://www.cei.org/pdfs/pediatric-ruling.pdf
U.S. Department of Health and Human Services - Pediatric Advisory Subommittee Ethical Issues Day 1 - November 15, 1999 - (291 pages) http://www.medicigroup.com/resources/Resources-Ethics%20&%20Patient%20Recruitment.pdf
Swissmedic Journal 1/2002 (32 pages) http://www.swissmedic.ch/files/pdf/01_2002.pdf
Swissmedic - home page (english) http://www.swissmedic.ch/?lang=2
Commission Regulation (EC) No 240/96 of 31 January 1996 on the application of Article 85 (3) of the Treaty to certain categories of technology transfer agreements http://europa.eu.int/eur-lex/en/lif/dat/1996/en_396R0240.html
Commission evaluation report on the transfer of technology block exemption regulation n° 240/96 (44 pages)
Technology transfer agreements under article 81
http://www.europa.eu.int/comm/competition/antitrust/technology_transfer/en.pdf
Federal Council - Message relatif à la révision de la loi sur les cartels - http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/MESSAGE/Message_relatif_a_la_revision_de_la_loi_sur_les%20cartels.pdf
Importations parallèles et droit des brevets Rapport du Conseil fédéral du 8 mai 2000 en réponse à la question de la Commission de l'économie et des redevances du Conseil national (CER) du 24 janvier 2000 - (from page 38) http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/MESSAGE/Message_relatif_a_la_revision_de_la_loi_sur_les%20cartels.pdf
J.C. Dumon, M. Sneyers et W. Moens - Report: First Gene Therapy Related Death - Belgian Biosafety Council - 2000 - (20 pages) http://biosafety.ihe.be/GT/regulatory/RapportEN27_06_2001.pdf
Gene Therapy Advisory Committee - Health Departments of the United Kingdom - 1999 - (58 pages) http://www.doh.gov.uk/genetics/gtac6.pdf
FDA - Warning Letter of March 3, 2000 to the University of Pennsylvania in relation with the death of Jesse Gelsinger during a clinical trial http://www.fda.gov/foi/warning_letters/m3435n.pdf
USPTO - Patenting By Geographic Region (State and Country), Breakout by Technology Class Count of 1996 - 2000 Utility Patent Grants By Calendar Year of Grant http://www.uspto.gov/web/offices/ac/ido/oeip/taf/clsstc/regions.htm
Institute of Medicine - Small Clinical Trials: issues and challenges - 2001 http://books.nap.edu/books/0309073332/html/R1.html#pagetop
Keith E. Maskus - Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries - Final Report to WIPO - April 2001 - (85 pages) http://www.wipo.int/about-ip/en/studies/pdf/ssa_maskus_pi.pdf
Christopher Heath - Parallel Imports and International Trade - WIPO - (12 pages) http://www.wipo.org/sme/en/documents/pdf/atrip_gva_99_6.pdf
Parallel Importing A Theoretical and Empirical Investigation - Report to Ministry of Commerce - Prepared by NZIER - February 1998 http://www.med.govt.nz/buslt/int_prop/parallel/index.html#TopOfPage
K Balasubramaniam - Equitable Pricing, Affordability and Access to Essential Drugs in Developing Countries: Consumers Perspective - WTO - (12 pages) http://www.wto.org/english/tratop_e/trips_e/hosbjor_presentations_e/35balasubramaniam_e.pdf
Conseil national - Motion CSEC-CN (00.455). Autorisation du diagnostic préimplantatoire lors de risque grave - March 20, 2002 http://www.parlament.ch/ab/frameset/f/n/4612/55916/f_n_4612_55916_55939.htm
WHO - Lignes Directrices Opérationnelles pour les Comités d’Ethique chargés de l’évaluation de la Recherche Biomédicale - 2000 - (19 pages) http://www.who.int/tdr/publications/publications/pdf/ethicsfr.pdf
Critique internationale des essais suisses de prescription d’héroïne Rapport de la Commission externe d’experts de l’OMS Prises de position de l’Organe international de contrôle des stupéfiants (OICS) - (53 pages) http://www.aegd.ch/pdf/kritik_franz.PDF
Swiss Ethics Committee on Non-human Gene Technology Avis relatif au projet de loi fédérale sur la transplantation d'organes, de tissus et de cellules (loi sur la transplantation, LTx) mis en consultation - (11 pages) http://www.buwal.ch/stobobio/ekah/pdf/280200f.pdf
Helsinki Declaration - World Medical Association - Ethical Principles for Medical Research Involving Human Subjects - last amendment 52nd WMA General Assembly, Edinburgh, Scotland, October 2000 - (5 pages) http://www.wma.net/e/policy/17c.pdf
Title 21--Food and Drugs Chapter I - - Part 50--Protection of Human Subjects http://www.access.gpo.gov/nara/cfr/waisidx_00/21cfr50_00.html
Title 21--Food and Drugs Chapter I-- Part 56--Institutional Review Boards http://www.access.gpo.gov/nara/cfr/waisidx_00/21cfr56_00.html
The Belmont Report - Ethical Principles and Guidelines for the Protection of Human Subjects of Research - April 18, 1979 http://ohsr.od.nih.gov/mpa/belmont.php3
US - Title 45 CFR Part 46 - Protection Of Human Subjects http://ohsr.od.nih.gov/mpa/45cfr46.php3
Guidelines for the Conduct of Research Involving Human Subjects at the National Institutes of Health http://ohsr.od.nih.gov/guidelines.php3
IRB Protocol Review Standards - Minimal regulatory requirements for IRB review, discussion and documentation in the meeting minutes http://ohsr.od.nih.gov/info/checklist_IRB_protocol.html
IRB - OHSR Information Sheets http://ohsr.od.nih.gov/info/
Address by Joel I. Klein - Cross-Licensing and Antitrust Law -Before the American Intellectual Property Law Association - San Antonio Marriott Rivercenter San Antonio, Texas - May 2, 1997 http://www.apeccp.org.tw/doc/USA/Policy/speech/1123.htm
WTO - Ministerial Declaration - Adopted on 14 November 2001 - (10 pages) http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.pdf
WTO -Declaration on the TRIPS Agreement and Public Health - Adopted on 14 November 2001 - (2 pages) http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.pdf
WTO - Implementation-Related Issues and Concerns - Decision of 14 November 2001 - (8 pages) http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_implementation_e.pdf
FTC - In the Matter of 180-Day Generic Drug Exclusivity for Abbreviated New Drug Applications - Comment of the Staff of the Bureau of Competition and of Policy Planning of the FTC - November 4, 1999 http://www.ftc.gov/be/v990016.htm
Swissmedic - Formulaire de base pour la soumission d'un projet de recherche biomédicale http://www.swissmedic.ch/files/pdf/f_FormEKAntrag.doc
Swissmedic - Formulaire d'avis de la Commission d'éthique de la recherche http://www.swissmedic.ch/files/pdf/f_FormEKBeschluss.doc
Swissmedic - Formulaire de notification pour les essais cliniques de médicaments http://www.swissmedic.ch/files/pdf/B3.1.121_Formulair_de_notification_pour_les_essais_cliniques_de_m%E9dicaments.dot
Swissmedic - list of ethics committee http://www.swissmedic.ch/files/pdf/Liste_Ethikkommissionen-f.pdf
Swissmedic - Commentaires concernant le formulaire «Demande d’autorisation / modification» http://www.swissmedic.ch/files/pdf/Commentaires%20sur%20le%20formulaire%20demande%20d%27autorisation%20-%20modification.pdf
OClin - Federal Ordinance on clinical trials http://www.admin.ch/ch/f/rs/8/812.214.2.fr.pdf
Préposé fédéral à la protection des données - Guide relatif au traitement de données personnelles dans le domaine médical - (53 pages) http://www.edsb.ch/f/doku/leitfaeden/medizin.pdf
Conseil de l'Europe Comité des Ministres Recommandation No R(90)3 du Comité des Ministres aux Etats membres sur la recherche médicale sur l'être humain adoptée par le Comité des Ministres le 6 février 1990 http://www.inserm.fr/ethique/Ethique.nsf/397fe8563d75f39bc12563f60028ec43/325e8f4b601fa154c125675400383408?OpenDocument
COMITE DIRECTEUR POUR LA BIOETHIQUE (CDBI) - Développement dans le domaine de la bioéthique dans les Etats membres,
dans les autres Etats et dans les organisations internationales - Strasbourg, le 26 Octobre 2001 - (83 pages)
http://www.legal.coe.int/bioethics/pdf/CDBI-INF(2001)6F.pdf
The Danish Council of Ehtics - Genetic investigation of Healthy Subjects - Report on Presymptomatic Gene Diagnosis http://www.etiskraad.dk/publikationer/genetic/ren.htm
HGC and the Human Fertilisation Embryology Authority (HFEA) - Outcome of the Public Consultation on Preimplantation Genetic Diagnosis - (33 pages) http://www.hgc.gov.uk/business_publications_pgdoutcome.pdf
Human Genetics Commission - First Annual Report- (58 pages) http://www.hgc.gov.uk/business_publications_annualreport_first.pdf
CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects - Revised draft, January 2002 http://www.cioms.ch/frame_guidelines_january_2002.htm
CIOMS - The Declaration of Inuyama - Human Genome Mapping, Genetic Screening and Gene Therapy http://www.cioms.ch/frame_1990_texts_of_guidelines.htm
CIOMS - International Guiding Principles for Biomedical Research Involving Animals (1985) http://www.cioms.ch/frame_1985_texts_of_guidelines.htm
EU - Directive 2001/20/EC relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use http://www.efgcp.org/webdocs/guidelines_for_retention.pdf
US - 106TH Congress 1ST Session H. R. 626 - "Health Care Research and Development and Taxpayer Protection Act’’ http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=106_cong_bills&docid=f:h626ih.txt.pdf
WHO WTO - Report of the Workship on differential pricing and financing of essential Drug - April 2001 - (27 pages) http://www.who.int/medicines/library/edm_general/who-wto-hosbjor/wholereporthosbjorworkshop-fin-eng.pdf
S. Jacobzone - Pharmaceutical Policies on OECD Countries : Reconciling Social and Industrial Goals - Labour Market and Social Policy - Occasional Papers No. 40 - (100 pages) http://www.olis.oecd.org/OLIS/2000DOC.NSF/c5ce8ffa41835d64c125685d005300b0/c125685b0057c558c12568c400331a1e/$FILE/00075948.PDF
Federal Department of Justice - Explications relatives à l'ordonnance sur la procréation médicalement assistée - (6 pages) http://www.ofj.admin.ch/themen/fortpflmed/vnvo-ber-fmedv-f.pdf
Federal Department of Justice - Explications relatives à l'ordonnance sur la Commission nationale d'éthique dans le domaine de la médecine humaine - (4 pages) http://www.ofj.admin.ch/themen/fortpflmed/vnvo-ber-vnek-f.pdf
Loi fédérale sur la protection des données (LPD) du 19 juin 1992 -RS 235.1 - (16 pages) http://www.admin.ch/ch/f/rs/2/235.1.fr.pdf
Proposed changes to the Federal Law on Data Protection (LPD) - (19 pages) http://www.ofj.admin.ch/themen/datenschutz/bg-revision-f.pdf
Avant-projet et rapport explicatif relatif à la révision de la loi fédérale sur la protection des données; Protocole additionnel à la Convention pour la protection des personnes à l'égard du traitement automatisé des données à caractère personnel http://www.ofj.admin.ch/themen/datenschutz/vn-ber-f.pdf
United Kingdom - Advice to Research Ethics Committees - Points to consider in ethical review of medical research involving genetic testing - October 1998 - (13 pages) http://www.doh.gov.uk/pub/docs/doh/recrev3.pdf
FDA - Guidance for Industry - Content and format of investigational new drug applications (inds) for phase 1 studies of drugs, including wellcharacterized, therapeutic, biotechnology-derived products - (18 pages) http://www.fda.gov/cder/guidance/phase1.pdf
FDA - Guidelines for Drug Master Files - September 1989 http://www.fda.gov/cder/guidance/dmf.htm
Federal Food, Drug and Cosmetic Act - Portions revised or new- As Amended by the FDA Modernization Act of 1997 http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm
ICH - Guidance for Industry E 10 Choice of Control Group and Related Issues in Clinical Trials - May 2001 - (37 pages) http://www.fda.gov/cder/guidance/4155fnl.pdf
FDA - Guidance for Industry
Acceptance of Foreign
Clinical Studies -March 2001 - (4 pages)
http://www.fda.gov/cder/guidance/fstud.pdf
FDA - Information Sheets - Guidance for Institutional Review Boards and Clinical Investigators- IRB Operations and Clinical Investigation Requirements - 1998 Update http://www.fda.gov/oc/ohrt/irbs/default.htm
EMEA - Fees payable to the EMEA - Human Medicinal Products http://www.emea.eu.int/htms/general/admin/fees/feesh.htm http://www.emea.eu.int/pdfs/general/direct/fees/711499en.pdf
EMEA - EMEA/17424/01 Position Statement on the Use of Placebo in Clinical Trials with regard to the Revised Declaration of Helsinki - June 2001 http://www.emea.eu.int/pdfs/human/press/pos/1742401en.pdf
EMEA - Market Authorisation Withdrawals (Also includes Suspensions of MA) http://www.emea.eu.int/htms/human/withdraw/withdraw.htm
EMEA - EMEA/H/30313/98 Revision 1 Procedure for Notifications of Parallel Distribution of Centrally Authorised Medicinal Products - (page 4) http://www.emea.eu.int/pdfs/human/parallel/3031398en.pdf
EMEA - CPMP Opinions on approval or refusal of marketing authorizations http://www.emea.eu.int/htms/human/opinion/opinion.htm
EMEA - CPMP/EWP/462/95 Note for Guidance on Clinical Investigation of Medicinal Products in Children (CPMP adopted March 97) - (12 pages) http://www.emea.eu.int/pdfs/human/ewp/046295en.pdf
EMEA - CPMP/EWP/240/95 Note for Guidance on Fixed Combination Medicinal Products (CPMP adopted April. 96) - (5 pages) http://www.emea.eu.int/pdfs/human/ewp/024095en.pdf
U.S. - EC MRA (Mutual Recognition Agreement) Pharmaceutical Good Manufacturing Practices Annex - Sectoral Annex for Pharmaceutical Good Manufacturing Practices GMPs) - (29 pages) http://pharmacos.eudra.org/F2/mra/doc/mraecus.pdf
U.S. - EC MRA - Joint Procedure for the Information Exchange of Serious or Life-Threatening Human / Animal Pharmaceutical Product Quality Defects and Recalls - (7 pages) http://www.emea.eu.int/pdfs/technical/mra/usa/008600en.pdf
FDA - Compliance Program Guidance Manual For FDA Staff - Compliance Program 7348.811 - Bioresearch Monitoring: Clinical Investigators http://www.fda.gov/ora/compliance_ref/bimo/7348_811/default.htm
FDA - Compliance Program 7348.810 - Bioresearch Monitoring Sponsors, Contract Research Organizations and Monitors - Date of Issuance: February 21, 2001 - Guidance for FDA Staff http://www.fda.gov/ora/compliance_ref/bimo/7348_810/default.htm
FDA - Good Laboratory Practice - GLP Final Rule - (81 pages) http://www.fda.gov/ora/compliance_ref/bimo/GLP/78fr-glpfinalrule.pdf
WHO - WHO Technical Report Series, No. 850, 1995, Annex 3 - Guidelines for good clinical practice (GCP) for trials on pharmaceutical products - (35 pages) http://www.who.int/medicines/library/par/ggcp/GCPGuidePharmatrials.pdf
WHO - General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine - (80 pages) http://www.who.int/medicines/library/trm/who-edm-trm-2000-1/who-edm-trm-2000-1.pdf
WHO - Criteria for Medicinal Drug Promotion - (8 pages) http://www.who.int/medicines/library/dap/ethical-criteria/criteriamedicinal.pdf
WHO, MSF and others - Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS. May 2001 - (38 pages) http://www.who.int/medicines/library/par/hivrelateddocs/sourcesandprices31may01.pdf
WHO and UNAIDS - Patent situation of HIV/AIDS-related drugs in 80 countries - Geneva, January 2000 - (16 pages) http://www.who.int/medicines/library/par/hivrelateddocs/patentshivdrugs.pdf
Council Directive 93/42/EEC of 14 June 1993 concerning medical devices http://europa.eu.int/eur-lex/en/lif/dat/1993/en_393L0042.html
Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices http://europa.eu.int/eur-lex/en/lif/dat/1990/en_390L0385.html
Swissmedic - form - requête d'autorisation d'exploitation - (fabrication, importation, exportation, commerce, etc.) - (3 pages) http://www.swissmedic.ch/files/pdf/B3.3.12-f.pdf
Swissmedic - form - requête d'autorisation d'exploitation - annexe A - Fabrication de médicaments (manufacture of drugs) - (4 pages) http://www.swissmedic.ch/files/pdf/B3.3.13-f.pdf
Swissmedic - form - requête d'autorisation d'exploiter - annexe B - Importation de médicaments (prêts à l'emploi) (drug imports) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.3.14-f.pdf
Swissmedic - form - requête d'autorisation d'exploiter - annexe C - Commerce de gros de médicaments (drug wholesaler authorization) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.3.15-f.pdf
Swissmedic - form - requête d'autorisation d'exploiter - annexe D - Exportation de médicaments (prêts à l'emploi) (ready-made drug exports) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.3.16-f.pdf
Swissmedic - form - requête d'autorisation d'exploiter - annexe E - Commerce à l'étranger de médicaments (sale of drugs in foreign countries) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.3.17-f.pdf
Swissmedic - form - requête d'autorisation d'exploiter - annexe F - Prélèvement de sang pour la transfusion ou la fabrication de médicaments (blood taking for transfusion / drug manufacturing) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.3.17-f.pdf
Swissmedic - form - demande d'autorisation / modification - (4 pages) http://www.swissmedic.ch/files/pdf/B3.1.11-f.pdf
Swissmedic - form - announce d'effets indésirables suspectés d'un médicament (EI) (possible drug adverse event) - (2 pages) http://www.swissmedic.ch/files/pdf/B3.2.16_Formulaire_d%27annoce_EI.pdf
Swissmedic - form - demande d'octroi d'une autorisation Swissmedic pour médicament à l'expiration de l'enregistrement OICM - (change from IOCM to Swissmedic authorization) (4 pages) http://www.swissmedic.ch/files/pdf/B3.1.96_demande_d%27octroi_%E0_l%27%E9ch%E9ance_d%27enregistrement_OICM-usage_humain.dot
Swissmedic - form - statut des demandes d'autorisation déposées à l'étranger http://www.swissmedic.ch/files/pdf/B3.1.92%20demandes%20d%27autorisation%20d%E9pos%E9e%20%E0%20l%27%E9tranger.doc
Swissmedic - form - produit d'origine animale présentant un risque d'EST - (4 pages) http://www.swissmedic.ch/files/pdf/B3.1.91-f.pdf
Swissmedic - form - renseignements concernant les fabricants - (6 pages) http://www.swissmedic.ch/files/pdf/B3.1.28-f.pdf
Swissmedic - list of countries from which imports of drugs in Switzerland are possible (following a simplified procedure) http://www.swissmedic.ch/overall.asp?theme=0.00107&theme_id=362&nm4prm=cGFnZT0xJmlkPTE5NjM=
NIH - Public Health Service Policy relating to Distribution of Unique Research Result Resources produced with PHS Funding - NIH Guide , Volume 25, Number 23, July 12, 1996 http://grants1.nih.gov/grants/guide/notice-files/not96-184.html
NIH -Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources: Final Notice http://ott.od.nih.gov/NewPages/RTguide_final.html#guide
NIH - Implementation Issues for Human Embryonic Stem Cell Research - Frequently Asked Questions http://grants1.nih.gov/grants/stem_cell_faqs_topic.htm
NIH - Human Embryonic Stem cell registry http://escr.nih.gov/
NIH - Notice of criteria for federal funding of research on existing human embryonic stem cells and establishment of NIH human embryonic stem cell registry http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html
WIPO (monthly) magazine 2002 (access to pdf files) http://www.wipo.org/publications/general/121/2002/index.html
Résultats de la procédure de consultation sur la Convention internationale sur les droits de l'homme et la biomédecine - 6 pages) http://www.ofj.admin.ch/themen/bioeth/ve-ber-f.pdf
Rapport en vue de la procédure de consultation sur la Convention internationale sur la biomédecine - Septembre 1998 - (42 pages) http://www.ofj.admin.ch/themen/bioeth/vn-ber-f.pdf
WHO - Application for Inclusion of didanosine on WHO Model List of Essential Medicines http://www.who.int/medicines/organization/par/edl/didanosine.doc
WHO - Legal Status of Traditional Medicine and Complementary/Alternative Medicine: A Worldwide Review - (199 pages) http://www.who.int/medicines/library/trm/who-edm-trm-2001-2/LegalStatus-final.pdf
USTR - Report on Switzerland's barriers to trade - (4 pages) + foreword http://www.ustr.gov/reports/nte/2002/switzerland.PDF http://www.ustr.gov/reports/nte/2002/foreword.PDF
Health Care Inspectorate of the Netherlands - Marketing plans for medicinal products available on prescription only: the current situation - The Hague, July 2001, second revised edition http://www.healthyskepticism.org/editions/2002/IN04.htm
Swiss Expert Committee for Biosafety (EFBS/CFSB) - English home page - "the permanent federal advisory Committee on questions relating to the protection of people and the environment in the areas of gene- and biotechnology" http://www.buwal.ch/stobobio/cfsb/e/index.htm
ILO - International Labour Organization - An ILO code of practice on HIV/AIDS and the world of work - 2001 - (38 pages) http://www.ilo.org/public/english/protection/trav/aids/download/pdf/hiv_a4_e.pdf
Arrêté fribourgeois du 12 septembre 1995 concernant les essais cliniques sur l’être humain http://www.fr.ch/v_ofl_bdlf/en_vigueur/fra/8212022v0001.doc
Communication concernant l'appréciation des accords verticaux - Décision de la Commission de la concurrence du 18 février 2002 http://www.wettbewerbskommission.ch/site/f/medien/Medienmitteilungen.Par.0027.Pic2.pdf
FDA - Office of Medical Policy - Division of Drug Marketing, Advertising, and Communications - Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs Main Survey Results http://www.fda.gov/cder/ddmac/dtcindex.htm http://www.fda.gov/cder/ddmac/dtcfllw.htm
FDA - Division of Drug Marketing, Advertising, and Communications National Surveys of Prescription Medicine Information Received by Consumers http://www.fda.gov/cder/ddmac/Y2KTITLE.HTM
FDA - Evaluation of Written Prescription Information Provided in Community Pharmacies: An 8-State Study http://www.fda.gov/cder/calendar/meeting/rx2000/report1.htm
FDA - Center for Drug Evaluation and Research - Transcript of a Public Meeting: Current Status of useful written Prescription Drug Information for Patients, Volumes I and II - February 29, 2000 http://www.fda.gov/cder/ddmac/tranvol1.htm http://www.fda.gov/cder/ddmac/tranvol2.htm
FDA - Guidance for Industry Consumer-Directed Broadcast Advertisements - (6 pages) http://www.fda.gov/cder/guidance/1804fnl.pdf
FDA - Guidance for Industry - Industry-Supported Scientific and Educational Activities http://www.fda.gov/cder/guidance/isse.pdf
FDA - Guidance for Industry - Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling - Draft Guidance - (8 pages) http://www.fda.gov/cder/guidance/1955dft.pdf
FDA - Draft Guidance for Industry - Promoting Medical Products in a Changing Healthcare Environment; I. Medical Product Promotion by Healthcare Organizations or Pharmacy Benefits Management Companies (PBMs) - (6 pages) http://www.fda.gov/cder/guidance/1726dft.pdf
FDA - Guidance for Industry Using FDA-Approved Patient Labeling in Consumer-Directed Print Advertisements - (7 pages) http://www.fda.gov/cder/guidance/4114dft.pdf
Patent Law Statute - 35 U.S.C. - (68 pages) http://www.law.duke.edu/curriculum/courseHomepages/spring2002/369_01/patentstatute.pdf
Merck v. Kessler, 903 F. Supp. 964, (E.D.Va. 1983) http://www.law.berkeley.edu/institutes/bclt/courses/fall99/merck.html
Roche v. Bolar, 572 F. Supp. 255 (E.D.N.Y. 1983) http://www.law.berkeley.edu/institutes/bclt/courses/fall99/roche.html
Eli Lilly v. Medtronic, 15 U.S.P.Q.2.d 1121 (S. Ct. 1990) http://www.law.berkeley.edu/institutes/bclt/courses/fall99/lilly.html
Amgen v. Hoechst Marion Roussel and Transkaryotic Therapies, 3 F. Supp.2d 104 (D. Mass. 1998) http://www.law.berkeley.edu/institutes/bclt/courses/fall99/amgen.html
Berlex Laboratories v. Food and Drug Administration, 942 F. Supp. 19 (D.D.C. 1996) http://www.law.berkeley.edu/institutes/bclt/courses/fall99/berlex.html
FDA - Guidance List - (31 pages) http://www.fda.gov/cder/guidance/guidlist.pdf
ICH - Technical Requirements for Registration of Pharmaceuticals for Human Use - ICH M2 EWG Electronic Common Technical Document Specification - 2002 - (160 pages) http://www.fda.gov/cder/m2/eCTD%20Step%202/eCTD%20Specification%20v2-0-1.pdf
FDA - Electronic Common Technical Document FDA Regional Information - (14 pages) http://www.fda.gov/cder/regulatory/ersr/FDARegional/FDA_regional_eCTD/FDA%20Regional%20-%20Instructions.doc
FDA - Use of Placebo controls in developing countries - (13 pages) http://www.citizen.org/documents/1558attachment.pdf
AAC Consulting Group - Audit of Schering-Plough Manufacturing Facility - 2000, (15 pages) http://www.citizen.org/documents/schering200.pdf
White House Commission on Complementary and Alternative Medicine Policy - Final Report -March 2002 http://www.whccamp.hhs.gov/finalreport.html
C-318/90 Case decision of June 3, 1992 Hauptzollamt Mannheim / Boehringer Rec.1992,p.I-3495) http://www.curia.eu.int/common/recdoc/indexaz/en/c2.htm
C-285/91 - Judgment of 18/02/1993, Merck / Hauptzollamt Hamburg-Jonas (Rec.1993,p.I-729 http://www.curia.eu.int/common/recdoc/indexaz/en/c2.htm#C-427/93
High Level Group Set to Improve Equality of Access to New Medicines Across EU NEWS RELEASE Innovative Medicines and the EU Citizen – Swedish Session - (3 pages) http://dg3.eudra.org/F3/g10/docs/g10w_250102_2.pdf
FTC - Analysis to Aid Public Comment and Complaint and Agreement of FTC case against Biovail Corporation http://www.ftc.gov/os/2002/04/biovailanalysis.htm http://www.ftc.gov/os/2002/04/biovaildecision.htm http://www.ftc.gov/os/2002/04/biovailcomplaint.htm
Combating Deception in Dietary Supplement Advertising Remarks By Commissioner Sheila F. Anthony Before The Food and Drug Law Institute 45th Annual Educational Conference - Washington, DC - April 16, 2002 http://www.ftc.gov/speeches/anthony/dssp2.htm
FTC - Analysis of proposed consent order to aid public comment - In the Matter of Interstate Bakeries Corporation, File No. 012 3182 http://www.ftc.gov/os/2002/03/interstateana.htm
FTC - Analysis to Aid Public Comment - AHP unlawfully agreed with Schering-Plough Corporation to delay selling its generic version of Schering's K-Dur 20, http://www.ftc.gov/os/2002/02/ahpanalysis.htm
FTC - FTC Staff Opposes Alaska Proposal to Allow Physician Collective Bargaining - Proposed Legislation Would Significantly Increase Consumer Health Care Costs - January 2002 http://www.ftc.gov/opa/2002/01/alaskaphysicians.htm
FTC - Eli Lilly Settles FTC Charges Concerning Security Breach Company Disclosed E-mail Addresses of 669 Subscribers to its Prozac Reminder Service - January 2002 http://www.ftc.gov/opa/2002/01/elililly.htm
WHO - Draft Scaling Up Antiretroviral Therapy in Resource Limited Settings : Guidelines for a Public Health Approach - 2002 - (115 pages) http://www.who.int/HIV_AIDS/HIV_AIDS_Care/ARV_Draft_April_2002.pdf
Swissmedic - Evolution du nombre de prescriptions de RITALINE® (méthylphénidate) dans le canton de Neuchâtel entre 1996 et 2000 - (13 pages) http://www.newsmaker.ch/upload/customers/swissmedic/Enquête_Ritaline_Neuchâtel.pdf
Swissmedic - Commerce de médicaments par Internet -Rapport du groupe de travail « commerce électronique » à l’intention du directeur de l’OICM - (17 pages) http://www.swissmedic.ch/files/pdf/Rapport_e-commerce.pdf
FY 2001 Performance Report to Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 http://www.fda.gov/oc/pdufa/report2001/pdufareport.html
C-427/93, C-429/93 and C-436/93 - Judgment of the Court of 11 July 1996. Bristol-Myers Squibb v Paranova A/S and C. H. Boehringer - Repackaging of trade-marked products. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Proposed Bill by Senator Dorgan - To permit commercial importation of prescription drugs from Canada, and for other purposes. http://dorgan.senate.gov/meds.pdf
Rapport de la Commission de gestion du Conseil des Etats - Influence de la Confédération sur la maîtrise des coûts dans le domaine de la loi sur l’assurance-maladie – Analyse de deux exemples précis - 5 avril 2002 - (22 pages) http://www.parlament.ch/F/Veroeffentlichungen/Kommissionsberichte/KVG_GPK_S_f.pdf
Initiative parlementaire Indemnisation des victimes stérilisées de force - Avant-projet et rapport explicatif de la Commission des affaires juridiques du Conseil national du 6 novembre 2001 - (32 pages) http://www.ejpd.admin.ch/doks/mm/2002/020327b_entw-f.pdf
Mesures de maîtrise des coûts dans la LAMal - Mesures et marge de manœuvre des organes responsables de la Confédération Synthèse à l’attention de la Commission de gestion du Conseil des États - November 30, 2001 - (35 pages) http://www.parlament.ch/F/Veroeffentlichungen/Kommissionsberichte/KVGSynthese_PVK_f.pdf
US Trade Representative (USTR) - 2002 Special 301 Report Executive Summary - (35 pages) http://www.ustr.gov/reports/2002/special301-report.PDF
USTR Information on NAFTA http://www.ustr.gov/regions/whemisphere/nafta.shtml
Institute of Medicine - The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995) http://books.nap.edu/books/0309052440/html/1.html
U.S. Department of Health and Human Services' - Conference on Pharmaceutical Pricing Practices, Utilization, and Costs August 8th & 9th http://aspe.hhs.gov/health/reports/Drug-papers/index.htm
The Pediatric Exclusivity Provision - January 2001- Status Report to Congress - (57 pages) http://www.fda.gov/cder/pediatric/reportcong01.pdf
Pharmaceutical Industry Competitiveness Task Force - Final Report – March 2001 - (95 pages) http://www.doh.gov.uk/pictf/pictf.pdf
Institute of Medicine Rational Therapeutics for Infants and Children - Workshop Summary http://search.nap.edu/html/rational_therapeutics/
Recent Developments and Challenges in the Protection of intellectual property rights pharmaceuticals and biotechnological Inventions - May 2001 - (24 pages) http://www.wipo.org/ip-conf-bg/en/documents/pdf/sof01_2_5.pdf
U.S. Supreme Court decision - Thompson v. Western States Medical Center - No.01-344. Argued February 26, 2002 -- Decided April 29, 2002 - (19 pages) - free speech http://supct.law.cornell.edu/supct/pdf/01-344P.ZO http://supct.law.cornell.edu/supct/pdf/01-344P.ZC http://supct.law.cornell.edu/supct/pdf/01-344P.ZD
U.S. Supreme Court decision - Warner Jenkinson Co., Inc. v. Hilton Davis Chemical Co. (95-728), 520 U.S. 17 (1997). - patent law http://supct.law.cornell.edu/supct/html/95-728.ZO.html
U.S. Supreme Court decision - FDA v. Brown & Williamson Tobacco Corp. (98-1152) 153 F.3d 155, affirmed. (39 pages & 32 pages) - tobacco as a drug/device http://supct.law.cornell.edu/supct/pdf/98-1152P.ZO http://supct.law.cornell.edu/supct/pdf/98-1152P.ZD
U.S. Supreme Court decision - BRAGDON v. ABBOTT (97-156) 107 F.3d 934, vacated and remanded. - (29 pages) - AIDS disability http://supct.law.cornell.edu/supct/pdf/98-1152P.ZD
U.S. Supreme Court decision - Madsen v. Women's Health Ctr. (93-880), 512 U.S. 753 (1994). - abortion and free speech http://supct.law.cornell.edu/supct/html/93-880.ZO.html
Judgment of 23/04/2002, Merck, Sharp & Dohme - Case C-443/99.- Exhaustion of the rights conferred by the trade mark http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of 23/04/2002, Boehringer Ingelheim and others - C-143/00 - Exhaustion of the rights conferred by the trade mark http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Pharmaceuticals in the European Union - booklet - (31 pages) http://pharmacos.eudra.org/F2/pharmacos/docs/brochure/brochurenov99.pdf
FDA Backgrounder - FDA's Budget Request for FY 2002 http://www.fda.gov/opacom/backgrounders/budget.html
FDA - Milestones in U.S. Food and Drug Law History http://www.fda.gov/opacom/backgrounders/miles.html
FDA- FY 2002 Congressional Budget Request - Various documents http://www.fda.gov/oc/oms/ofm/budget/2002/2002budget.htm
JAAC 59.34 -Décision de la Commission fédérale de recours en matière de douanes du 27 octobre 1994 - Capsules Y http://www.vpb.admin.ch/franz/doc/59/59.34.html
Swiss Federal Institute of Intellectual Property - Patents - Directives pour l'examen quant au fond - (156 pages) http://www.ige.ch/F/jurinfo/pdf/dirpat.pdf
ATF 96 I 752 - Arrêt du TF sur la marque Enterocura http://wwwsrv1.bger.ch/atf/index/96_I.html
U.S. DOJ - Health Care Business Review Letters Inssued (Since 1993 Issuance of DOJ/FTC Health Care Antitrust Statements of Enforcement Policy: Current as of 1/27/97) http://www.usdoj.gov/atr/public/busreview/1032.htm
Richard G. Parker & David A. Balto - The Evolving Approach to Merger Remedies [published in Antitrust Report (May 2000)] http://www.ftc.gov/speeches/other/remedies.htm
Speech of Mary L. Azcuenaga - The Intersection of Antitrust and Intellectual Property: Adaptations, Aphorisms and Advancing the Debate http://www.ftc.gov/speeches/azcuenaga/alis.htm
U.S. DOJ - Antitrust Division Health Care Task Force - Recent Enforcement Actions http://www.usdoj.gov/atr/public/health_care/2044.htm
United States Court of Appeals - FTC v. Novartis - 2000 - Doan drug product - (9 pages) http://www.ftc.gov/os/2000/08/novartis.pdf
FTC - Final Order - In the Matter of Novartis - Doan drug product http://www.ftc.gov/os/1999/9905/novaord.htm
FTC - Opinion of the MTC in the matter of Novarti's doan drug product - (38 pages) http://www.ftc.gov/os/1999/9905/novartisopin.pdf
FTC - FTC Antitrust Actions in Pharmaceutical Services and Products - Washington D.C. 20580 May 30, 2000 http://www.ftc.gov/bc/rxupdate.htm
FDA - CDER Manual of Policies and Procedures MaPPs http://www.fda.gov/cder/mapp.htm
Legal protection of biotechnical inventions: Frequently Asked questions on scope and objectives of the EU Directive (98/44) http://europa.eu.int/comm/internal_market/en/indprop/invent/2k-39.htm
Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products http://pharmacos.eudra.org/F2/eudralex/vol-5/pdfs-en/921768en.pdf
Draft Guidance on the acceptability of trade names for medicinal products processed through the centralized procedure - 2002 - (5 pages) http://www.emea.eu.int/pdfs/human/regaffair/032898en.pdf
Procedure on the granting of marketing authorisations by central and Eastern European Countries for medicinal products for human use - December 1999 - (18 pages) http://www.il.waw.pl/centralised_procedure.pdf
Note for Guidance on Specifications: test procedures and acceptance criteria for biotechnological/biological products - (17 pages) http://www.emea.eu.int/pdfs/human/ich/036596en.pdf
Note for Guidance on Specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products - (19 pages) http://www.emea.eu.int/pdfs/human/qwp/282000en.pdf
David Reiffen and Michael R. Ward - Generic Drug Industry Dynamics - FTC - February, 2002 - (60 pages) http://www.ftc.gov/be/workpapers/industrydynamicsreiffenwp.pdf
Speech of Timothy J. Muris, Chairman of the Federal Trade Commission, before the Committee on Commerce, Science, and Transportation of Senate Washington, D.C. April 23, 2002 on the pharmaceutical industry http://www.ftc.gov/os/2002/04/pharmtestimony.htm
Competition and Intellectual Property Policy: The Way Ahead - Prepared Remarks of Timothy J. Muris Chairman of the FTC - before American Bar Association Antitrust Section Fall Forum - Washington, DC - November 15, 2001 http://www.ftc.gov/speeches/muris/intellectual.htm
Decision of United States Court of Appeals for the Federal Circuit - 01-1369, -1370 Minnesota Mining and Manufacturing Co. and Riker Laboratories and Alphapharm Pty. Ltd. .v. Barr Laboratories - Hatch Waxman http://www.ipo.org/2002/IPcourts/3M_v_Barr.htm
GAO - Issues in HHS’ Proposed Rule on Confidentiality of Personal Health Information - April 26, 2000 - (27 pages) http://www.gao.gov/new.items/he00106t.pdf
GAO - Prescription Drugs: Spending Controls in Four European Countries (Chapter Report, 05/17/94, GAO/HEHS-94-30). http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he94030.txt
GAO - DOD and VA Health Care - Jointly Buying and Mailing Out Pharmaceuticals Could Save Millions of Dollars - May 25, 2000 - (26 pages) http://www.presidentshealthcare.org/pdffiles/he00121t.pdf
GAO - Prescription Drug Benefits - Applying Private Sector Management Methods to Medicare - March 22, 2000 - (15 pages) http://www.gao.gov/new.items/he00084t.pdf
GAO - Medicare: Considerations for Adding a Prescription Drug Benefit (Testimony, 06/23/99, GAO/T-HEHS-99-153). http://frwebgate.access.gpo.gov/cgi-bin/useftp.cgi?IPaddress=162.140.64.21&filename=he99153t.txt&directory=/diskb/wais/data/gao
FDA - Notice - Establishment of Prescription Drug User Fee Rates for Fiscal Year 2000and 2002 http://www.fda.gov/cber/genadmin/fr-estab.pdf http://www.pharmcast.com/FederalRegistrar/Yr2002/011402/UserFee011602.htm
FDA - Cyber Letters 2000/2001/2002 http://www.fda.gov/cder/warn/cyber/cyber2000.htm http://www.fda.gov/cder/warn/cyber/cyber2001.htm http://www.fda.gov/cder/warn/cyber/cyber2002.htm
21 CFR (Code of Federal Regulations) Parts 210 and 211 Part 210 - Current Good Manufacturing Practice http://www.fda.gov/cder/dmpq/cgmpregs.htm
FDA - Main page on Good Manufacturing Practices http://www.fda.gov/cder/dmpq/index.htm
FDA - Compliance Program Guidance Manual for FDA Staff: Drug Manufacturing Inspections http://www.fda.gov/cder/dmpq/compliance_guide.htm
NIH - NIH Policy for Data and Safety Monitoring - June 10, 1998 http://grants1.nih.gov/grants/guide/notice-files/not98-084.html
FDA - Guidance Financial Disclosure by Clinical Investigators http://www.fda.gov/oc/guidance/financialdis.html
NIH - Guidance on Reporting Adverse Events to Institutional Review Boards for NIH-Supported Multicenter Clinical Trials - June 11, 1999 http://grants1.nih.gov/grants/guide/notice-files/not99-107.html
HHS - Institutional Review Board (IRB) Registration http://ohrp.osophs.dhhs.gov/humansubjects/assurance/irbs.htm
HHS - Informed Consent Checklist / Tips http://ohrp.osophs.dhhs.gov/humansubjects/assurance/consentckls.htm http://ohrp.osophs.dhhs.gov/humansubjects/guidance/ictips.htm
OHRP - Registration of an Institutional Review Board (IRB) or Independent Ethics Committee (IEC) http://ohrp.osophs.dhhs.gov/humansubjects/assurance/regirbt.htm
EMA - Annual Report 2001 - (72 pages) http://www.emea.eu.int/pdfs/general/direct/emeaar/005201en.pdf
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use http://www.eortc.be/Services/Doc/clinical-EU-directive-04-April-01.pdf
GAO - Intellectual Property - Industry and Agency Concerns Over Intellectual Property Rights - May 20, 2002 - (13 pages) http://www.gao.gov/new.items/d02723t.pdf
WHO, WHO medicines strategy Expanding access to essential drugs Report by the Secretariat - (6 pages) http://www.who.int/gb/EB_WHA/PDF/WHA55/ea5512.pdf
(federal) Bill S. 812 To amend the Federal Food, Drug, and Cosmetic Act to provide greater access to affordable pharmaceuticals. http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=107_cong_bills&docid=f:s812is.txt.pdf
FDA - A Trial of St. John's Wort (Hypericum perforatum) for the Treatment of Major Depression http://nccam.nih.gov/ne/press-releases/stjohnswort/q-and-a.htm
FDA - Medication Guide Accutane Capsules (isotretinoin) http://www.fda.gov/cder/drug/infopage/accutane/medicationguide.htm#important warnings
FDA - Division of Drug Marketing, Advertising, and Communications - Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs Main Survey Results http://www.fda.gov/cder/ddmac/dtcindex.htm http://www.fda.gov/cder/ddmac/dtcfllw.htm
UNDP - Global initiatives to create technologies for human development - Chapter 5 - (36 pages) http://www.undp.org/hdr2001/chapterfive.pdf
WIPO - Striking a Balance: Patents and Access to Drugs and Health Care http://www.wipo.int/about-ip/en/studies/publications/health_care.htm
Center for Drug Evaluation and Research - 2001 Report to the Nation - Improving Public Health Through Human Drugs - (50 pages) http://www.fda.gov/cder/reports/rtn/2001/rtn2001.pdf
FDA - 2002 Workshop on Pharmacogenetics / Pharmacogenomics in Drug Development and Regulatory Decision-Making - May 16-17th, 2002 - (65 pages) http://www.fda.gov/cder/calendar/meeting/phrma52002/workbook.pdf
U.S. Preventive Services Task Force (USPSTF) - Recommendations and Rationale Screening for Depression http://www.ahrq.gov/clinic/3rduspstf/depression/depressrr.htm
FDA - Inspection report of Abbott Laboratories (3 pages) http://www.citizen.org/documents/1619appendix.pdf
Institute of Medicine - Shaping the Future for Health Care Without Coverage :Too Little, Too Late - Summary - (8 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/Uninsured2FINAL/$file/Uninsured2FINAL.pdf
Institute of Medicine - Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (2002) http://www.nap.edu/books/030908265X/html/
Institute of Medicine - Exploring the Biological Contributions to Human Health: Does Sex Matter? - Summary - (8 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/DoesSexMatter8pager/$file/DoesSexMatter8pager.pdf
Institute of Medicine - Exploring the Map of Clinical Research for the Coming Decade: Symposium Summary, Clinical Roundtable, December 2000 - Summary - (8 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/CRR8pager3/$file/CRR8pager3.pdf
Institute of Medicine - Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences (May 21, 2001) http://books.nap.edu/html/health_behavior/
Institute of Medicine - Preserving Public Trust: Accreditation and Human Research Participant Protection Programs (April 17, 2001) - Summary - (6 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/IRB-6Pager/$file/IRB-6Pager.PDF
Institute of Medicine - Public Confidence and Involvement in Clinical Research: Symposium Summary, Clinical Roundtable, September 2000 - Summary - (8 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/CRR8pager2/$file/CRR8pager2.pdf
Institute of Medicine -Small Clinical Trials: Issues and Challenges (April 10, 2001) - Summary (6 pages) http://www.iom.edu/iom/iomhome.nsf/WFiles/SmallN6pager/$file/SmallN6pager.pdf
Institute of Medicine - Stem Cells and the Future of Regenerative Medicine (September 11, 2001) - 71 pages http://books.nap.edu/html/stem_cells/report.pdf
U.S. DOJ - TAP Pharmaceutical. Products Inc charged with Health Care Crimes http://www.usdoj.gov/opa/pr/2001/October/513civ.htm
White House Commission on Complementary and Alternative Medicine Policy Final Report - March 2002 http://www.whccamp.hhs.gov/finalreport.html
Institutional Animal Care and Use Committee Guidebook - 2002 - (230 pages) http://grants1.nih.gov/grants/olaw/GuideBook.pdf
Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity - August 2001 - (370 pages) http://iccvam.niehs.nih.gov/methods/invidocs/finalall.pdf
Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity - August 2001 - (100 pages) http://iccvam.niehs.nih.gov/methods/invidocs/guidance/iv_guide.pdf
Current Bibliographies in Medicine 93-1 -Laboratory Animal Welfare http://www.nlm.nih.gov/pubs/cbm/labanim.html
Advisory Committee on Human Radiation Experiments - Final Report http://tis.eh.doe.gov/ohre/roadmap/achre/report.html
Annual Progress Report of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) December 19, 2001 - (21 pages) http://iccvam.niehs.nih.gov/about/annrpt/annrpt01.doc
Public Health Service Policy on Humane Care and Use of Laboratory Animals - (24 pages) http://grants1.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf
Institute of Laboratory Animal Resources
Commission on Life Sciences National Research Council - Guide for the Care and Use of Laboratory Animals - 1996
http://www.nap.edu/readingroom/books/labrats/
Published Articles Office of Laboratory Animal Welfare http://grants1.nih.gov/grants/olaw/references/publishedarticles.htm
Animal Welfare Act and Regulations http://www.nal.usda.gov/awic/legislat/usdaleg1.htm
Département fédéral de l’intérieur - L’assurance-maladie sociale Analyse - Séance spéciale du Conseil fédéral du 22 mai 2002 - (55 pages) http://www.bsv.admin.ch/aktuell/presse/2002/f/02052301.pdf
Arrêt du TF sur la cession de créance à la pharmacie de l'assuré contre la caisse-maladie: page 50 à 57 http://www.bsv.admin.ch/publikat/rkuv/d/rkuv0106.pdf
Loi fédérale relative à la recherche sur les embryons surnuméraires et sur les cellules souches embryonnaires (Loi relative à la recherche sur les embryons, LRE) Rapport explicatif sur le projet de loi - Mai 2002 - (86 pages) http://www.bag.admin.ch/embryonen/bundesgesetz/f/erl_efg.pdf
Draft - Loi fédérale Projet relative à la recherche sur les embryons surnuméraires et sur les cellules souches embryonnaires http://www.bag.admin.ch/embryonen/bundesgesetz/f/entw_efg.pdf
Statement of Patricia L. Maher (DOJ) - The Importation of Bulk Counterfeit Pharmaceutical Products - October 3, 2000 http://www.usdoj.gov/criminal/cybercrime/FDCAover.htm
Draft - FDA Guidance for Industry on: Exports and Imports Under the FDA Export Reform and Enhancement Act of 1996 - February 1998 http://www.fda.gov/opacom/fedregister/frexport.html
Quality King Distributors v. L'Anza Research, 523 U.S. 135, 118 S. Ct. 1125, http://supct.law.cornell.edu/supct/pdf/96-1470P.ZO
Investigators' Reports Maker of Growth Hormone Feels Long Arm of Law - FDA Consumer magazine September-October 1999 http://www.fda.gov/fdac/departs/1999/599_irs.html
Tamar Nordenberg - Direct to You: TV Drug Ads That Make Sense - FDA Consumer magazine - January- February 1998 http://www.fda.gov/fdac/features/1998/198_ads.html
Statement of FTC Commissioner Orson Swindle Concurring in Part and Dissenting in Part in Novartis Corporation et al., Docket No. 9279 http://www.ftc.gov/os/1999/9905/novaswin.htm
FDA Guidance for Industry Consumer-Directed Broadcast Advertisements Questions and Answers http://www.fda.gov/cder/guidance/1804q&a.htm
OECD - The OECD Guidelines for Multinational Enterprises Revision 2000 - (67 pages) http://www.oecd.org/pdf/M000015000/M00015419.pdf
OECD - The OECD Declaration and Decisions on International Investment and Multinational Enterprises : Basic Texts - (35 pages) http://www.olis.oecd.org/olis/2000doc.nsf/c5ce8ffa41835d64c125685d005300b0/c125692700623b74c1256991003b5147/$FILE/00085743.PDF
FTC Complaint against online pharmacies (Viagra, Propecia Prescriptions Promoted With False Medical Claims Consumers' Medical and Financial Data Collected With False Privacy Assurances) http://www.ftc.gov/os/2000/07/iogcomp.htm
FDA - Rule - New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible http://www.fda.gov/OHRMS/DOCKETS/98fr/98n-0237-nfr0001-vol1.pdf
Commission de gestion du Conseil des Etats - Rapport - Requête à l’autorité de surveillance des cantons concernant la jurisprudence du Conseil fédéral en matière de recours contre les décisions tarifaires des gouvernements cantonaux April 2002 - 28 p http://www.parlament.ch/F/Veroeffentlichungen/Kommissionsberichte/KVGTarife_GPK_S_f.pdf
JAAC 66.16 Décision de la Commission fédérale de recours en matière d'alcool - August 20, 2001 http://www.vpb.admin.ch/franz/contenu_fr.html
Proposal for a Regulation and Directive - laying down Community procedures for the authorisation and supervision of medicinal products for human use - November 2001 - (200 pages) http://pharmacos.eudra.org/F2/review/doc/finaltext/011126-COM_2001_404-EN.pdf
FTC Charges Drug Manufacturers with Stifling Competition in Two Prescription Drug Markets - Hoechst Marion Roussel, Inc. / Andrx Corp.; / Abbott Laboratories / Geneva Pharmaceuticals - March 16, 2000 http://www.ftc.gov/opa/2000/03/hoechst.htm http://www.ftc.gov/os/2000/03/genevaabbpttanalysis.htm http://www.ftc.gov/os/2000/03/hoechstandrxcomplaint.htm http://www.ftc.gov/os/2000/03/abbottcmp.htm
Resolving Competitive Concerns, FTC Agreement Clears $182 Billion Merger of SmithKline Beecham and Glaxo Wellcome - December 18, 2000 http://www.ftc.gov/opa/2000/12/skb.htm http://www.ftc.gov/os/2000/12/glaxoana.htm http://www.ftc.gov/os/2000/12/glaxotrustagree.pdf http://www.ftc.gov/os/2000/12/glaxosmithklinecmp.pdf
FTC - Decision and Order - Docket No. C-3725 - In the Matter of Ciba-Geigy and Sandoz http://www.ftc.gov/os/1997/9704/c3725.do.htm
Communication from the European Communities and their member states to the trips council concept paper relating to paragraph 6 of the Doha declaration on the trips agreement and public health - (8 pages) http://trade-info.cec.eu.int/europa/2001newround/050-02-rev.pdf
Working document tiered pricing for medicines exported to developing countries, measures to prevent their re-importation into the EC market and tariffs in developing countries 22 April, 2002 http://europa.eu.int/comm/trade/pdf/med_wd.pdf
United States Senate Joint Economic Committee, The Benefits of Medical Research and the Role of the NIH, May 2000 - (64 pages) http://rxpolicy.com/studies/nih-randd-jec.pdf
ICH M2 EWG Electronic Common Technical Document Specification- Technical Requirements for registration of pharmaceuticals for human use - February 12, 2002 - (160 pages) http://www.fda.gov/cder/guidance/5017dft.pdf
ICH Q1E - Draft Consensus Guideline Evaluation of Stability Data - 7 February 2002 http://www.fda.gov/cder/guidance/4983dft.pdf
ICH Q1F Draft Consensus Guideline - Stability Data Package for Registration in Climatic Zones III and IV - February 7, 2002 - (5 pages) http://www.fda.gov/cder/guidance/4984dft.pdf
Swissmedic - Guide to the regulation of medical devices http://www.swissmedic.ch/md/files/leitf-e.html
Swissmedic - Checkliste documents pour essais cliniques de thérapie génique/ OGM http://www.swissmedic.ch/files/pdf/B3.1.83_Checkliste_documents_essais_cliniques_th%E9rapie_g%E9nique_OGM.doc http://www.swissmedic.ch/files/pdf/B3.1.82_Requ%EAte_autorisation_essais_cliniques_th%E9rapie_g%E9nique_OGM.dot
Swiss Ethics Committee on Non-human Gene Technology - Avis relatif à la concrétisation de la notion de dignité de la créature dans le cadre du projet de révision de la loi sur la protection des animaux - (11 pages) http://www.buwal.ch/stobobio/ekah/pdf/171199f.pdf http://www.buwal.ch/stobobio/ekah/pdf/tier_f.pdf
Swiss Ethics Committee on Non-human Gene Technology - Avis relatif à l’article 120, alinéa 2, de la version française de la constitution fédérale -.(2 pages) http://www.buwal.ch/stobobio/ekah/pdf/0300f.pdf
Protection de la propriété intellectuelle dans le domaine de la biotechnologie: considérations éthiques concernant la brevetabilité des animaux et des plantes Une contribution à la discussion - (15 pages) http://www.buwal.ch/stobobio/ekah/pdf/diskussion_f.pdf
Swiss Ethics Committee on Non-human Gene Technology - Evaluation éthique de la technologie «Terminator» - (12 pages) http://www.buwal.ch/stobobio/ekah/pdf/term_f.pdf
Swiss Ethics Committee on Non-human Gene Technology - Prise de position de la CENH sur la réglementation des disséminations d’organismes génétiquement modifiés dans l’environnement - (3 pages) http://www.buwal.ch/stobobio/ekah/pdf/120500_f.pdf
Swiss Ethics Committee on Non-human Gene Technology - Prise de Position provisoire sur le projet de Gen-Lex http://www.buwal.ch/stobobio/ekah/pdf/050998f.pdf
Classeur "Protection des animaux - expériences sur animaux et méthodes de substitution" http://www.bvet.admin.ch/tierschutz/f/berichte_publikationen/tierversuche/1_index.html
Réorientation du droit suisse sur la protection des animaux Rapport du groupe de travail à l’intention de l’Office vétérinaire fédéral du 12 août 1998 http://www.bvet.admin.ch/tierschutz/f/berichte_publikationen/tierschutzpolitik/98-10-01-bericht.html
Swiss Federal Act on Animal Protection of March 9, 1978 (State as per July 1, 1995) http://www.bvet.admin.ch/tierschutz/e/gesetzgebung/tschg_tschv_version_2001.pdf
Federal Veterinary Office - Form A and Form B for experiments on animals http://www.bvet.admin.ch/tierschutz/d/vollzugshilfen/tv-formulare/formular_a_e.pdf http://www.bvet.admin.ch/tierschutz/e/vollzugshilfen/tv-formulare/c_form_engl.pdf
Final Report - Evaluation of Written Prescription Information Provided in Community Pharmacies, 2001 http://www.fda.gov/cder/reports/prescriptionInfo/default.htm
3 Warning Letters on Good Laboratory Practices http://www.fda.gov/foi/warning_letters/g1990d.pdf http://www.fda.gov/foi/warning_letters/g1864d.pdf http://www.fda.gov/foi/warning_letters/g2044d.pdf
Rapport du 18 mai 1999 de la Commission des affaires juridiques du Conseil national Avis du Conseil fédéral du 20 septembre 1999 http://www.ofj.admin.ch/themen/tiere/stellungnahme-br-f.pdf
Révision de la loi sur la protection des animaux
Rapport explicatif de l'avant-projet - September 2001 - (23 pages)
http://www.bvet.admin.ch/info-service/f/vernehmlassungen/010921tschg_erl.pdf
Débat parlementaire sur l'initiative relative au statut de l'animal http://www.parlament.ch/ab/frameset/d/s/4604/17669/d_s_4604_17669_17799.htm http://www.parlament.ch/ab/frameset/d/s/4612/49803/d_s_4612_49803_50511.htm?DisplayTextOid=50512 http://www.parlament.ch/ab/data/d/s/4612/49803/d_s_4612_49803_50511.htm
Rapport de la Commission des affaires juridiques (CAJ) du 18 mai 2000 sur l'initiative "Les animaux dans l'orde juridique suisse" (CAJ-CE) http://www.parlament.ch/afs/data/f/bericht/1999/f_bericht_s_k25_0_19990467_01.htm#a2
Message du Conseil fédéral concernant les initiatives populaires fédérales «pour un meilleur statut juridique des animaux (Initiative pour les animaux)» et «Les animaux ne sont pas des choses!» du 25 avril 2001 - (19 pages) http://www.admin.ch/ch/f/ff/2001/2390.pdf
TFA - Federal Insurance Tribunal - court decision on musicotherapy - I 510/00 Mh - April 29, 2002 http://wwwsrv.bger.ch/cgi-bin/AZA/MapProcessorCGI_AZA?mapfile=pull/ConvertDocFrameCGI.map&ri=fr&lang=fr&ds=AZA_pull&d=29.04.2002_I_510%2f00&pa=2%7emusicotherapie%4010%7emusicotherapie%404%7e&
Council Directive - of 24 November 1986 - 86/609/EEC - on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes http://europa.eu.int/comm/food/fs/aw/aw_legislation/scientific/86-609-eec_en.pdf
Council Directive of 7June 1988 on the inspection and verification of Good Laboratory Practice (GLP) (88/320/EEC) http://europa.eu.int/eur-lex/en/consleg/pdf/1988/en_1988L0320_do_001.pdf
OTA - Unconvention Cancer Treatments - September 1990 OTA-H-405 - (297 pages) http://www.ota.nap.edu/pdf/data/1990/9044.PDF
OTA - Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues OTA-BP-H-163 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9524/9524.PDF
OTA - The Effectiveness of Research and Experimentation Tax Credits - 1995 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9558/9558.PDF
OTA - Federal Technology Transfer and the Human Genome Project - OTA-BP-EHR-162 - 1995 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9526/9526.PDF
OTA - Impacts of Antibiotic-Resistant Bacteria OTA-H-629 -1995 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9503/9503.PDF
OTA - Defensive Medicine and Medical Malpractice - OTA-H-602 - 1994 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1994/9405/9405.PDF
OTA - International Comparisons of Administrative Costs in Health Care - OTA-BP-H-135 - 1994 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1994/9417/9417.PDF
OTA - International Health Statistics: What the Numbers Mean for the United States - OTA-BP-H-116 - 1994 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1994/9418/9418.PDF
OTA - Researching Health Risks - OTA-BBS-570 - 1993 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1993/9352/9352.PDF
OTA - Drug Labeling in Developing Countries - 1993 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1993/9321/9321.PDF
OTA - Pharmaceutical R&D: Costs, Risks, and Rewards - OTA-H-522 - 1993 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1993/9336/9336.PDF
OTA - Biomedical Ethics in U.S. Public Policy OTA-BP-BBS-105 -1993 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1993/9312/9312.PDF
Joint Economic Committee - Health Insurance Tax Credits: the Wrong Prescription for the Uninsured - February 13, 2002 - (13 pages) http://jec.senate.gov/Documents/106th/Reports/hitaxcredit13feb2002.pdf
The Evaluation of Abstinence Education Programs Funded Under Title V Section 510: Interim Report http://aspe.hhs.gov/hsp/abstinence02/ http://aspe.hhs.gov/hsp/abstinence02/execsum.htm#TOC
Rapport sur le Cannabis de la Commission fédérale pour les questions liées aux drogues - CFLD - Septembre 1999 - (114 pages) http://www.bag.admin.ch/sucht/publikationen/f/cannabis.pdf
Assurance-maladie : Mesures et train de réformes du Conseil fédéral et du DFI - July 3, 2002 http://www.ofas.admin.ch/aktuell/presse/2002/f/02070303.htm http://www.ofas.admin.ch/aktuell/presse/2002/f/02070304.pdf http://www.ofas.admin.ch/aktuell/presse/2002/f/02070307.pdf http://www.ofas.admin.ch/aktuell/presse/2002/f/02070308.pdf
Swissmedic - Evolution du nombre de prescriptions de RITALINE® (méthylphénidate) dans le canton de Neuchâtel entre 1996 et 2000 - (13 pages) http://www.swissmedic.ch/files/pdf/Enqu%EAte_Ritaline_Neuch%E2tel.pdf
FDA - Guidance for Industry Prescription Drug Marketing Act Regulations for Donation of Prescription Drug Samples to Free Clinics - (7 pages) http://www.fda.gov/cder/guidance/4932dft.PDF
FDA - Guidance for Industry Providing Regulatory Submissions in Electronic Format — ANDAs - (10 pages) http://www.fda.gov/cder/guidance/5004fnl.pdf
OTA - The Biology of Mental Disorders OTA-BA-538 - September 1992 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1992/9237/9237.PDF
OTA - Does Health Insurance Make a Difference? OTA-BP-H-99 - September 1992 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1992/9212/9212.PDF
OTA - Biotechnology in a Global Economy - OTA-BA-494 - October 1991 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1991/9110/9110.PDF
OTA - Review of a Protocol for a Study of Reproductive Health Outcomes Among Women Vietnam Veterans - December 1991 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1991/9135/9135.PDF
GAO Report on Research Universities' Administration of the Bayh-Dole Act - May 7, 1998 - (7 pages) http://www.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:rc98126.txt.pdf
WHO - Operational Guidelines for Ethics Committees That Review Biomedical Research - 2000 - (39 pages) http://www.who.int/tdr/publications/publications/pdf/ethics.pdf
Governance arrangements for NHS Research Ethics Committees - July 2001 - (35 pages) http://www.doh.gov.uk/research/documents/gafrec.pdf
South West Local Research Ethics Committees Common Application Form Guidance Notes - August 2001 - (19 pages) http://www.doh.gov.uk/research/swro/rd/ethics/ethforms/ethguid.pdf
Australian commonwealth Department of Health and Aged Care - Human Research Ethics Committees and the Therapeutic Goods Legislation - June 2001 - (66 pages) http://www.health.gov.au/tga/docs/pdf/unapproved/hrec.pdf
New Zealand Ministry of Health - Operational Standard for Ethics Committees - March 2002 - (145 pages) http://www.moh.govt.nz/moh.nsf/c7ad5e032528c34c4c2566690076db9b/ffc06a2c2009deeecc256b9400787b61/$FILE/OperationalStandard_final.pdf
New Zealand - Guide on Codes of Ethical Conduct - May 2002 (28 pages) http://202.78.129.207/biosecurity/animal-welfare/naeac/papers/naeaccec.pdf
Proceedings of the 5th European Conference of National Ethics Committees (COMETH) 4-5 September 2000, - Strasbourg - (81 pages) http://www.legal.coe.int/bioethics/gb/pdf/5e_conference.pdf
Ordonnance de l'OFSP du 8 novembre 1996 sur les précurseurs et autres produits chimiques utilisés pour la fabrication de stupéfiants et de substances psychotropes (Ordonnance de l'OFSP sur les précurseurs, O Prec-OFSP) http://www.admin.ch/ch/f/rs/8/812.121.31.fr.pdf
Ordonnance du 8 mars 1999 sur la prescription médicale d'héroïn http://www.admin.ch/ch/f/rs/8/812.121.6.fr.pdf
Loi fédérale du 21 mars 1969 sur le commerce des toxiques (Loi sur les toxiques http://www.admin.ch/ch/f/rs/8/813.0.fr.pdf
Ordonnance du 19 septembre 1983 sur les toxiques (Otox) http://www.admin.ch/ch/f/rs/8/813.01.fr.pdf
Ordonnance du 2 février 2000 sur les Bonnes pratiques de laboratoire (OBPL) http://www.admin.ch/ch/f/rs/8/813.016.5.fr.pdf
Loi fédérale du 18 décembre 1998 sur la procréation médicalement assistée (LPMA) http://www.admin.ch/ch/f/rs/8/814.90.fr.pdf
Ordonnance du 4 décembre 2000 sur la procréation médicalement assistée (OPMA) http://www.admin.ch/ch/f/rs/8/814.902.2.fr.pdf
Ordonnance du 4 décembre 2000 sur la Commission nationale d'éthique dans le domaine de la médecine humaine (OCNE) http://www.admin.ch/ch/f/rs/8/814.903.fr.pdf
Ordonnance du 25 août 1999 sur l'utilisation d'organismes dans l'environnement (Ordonnance sur la dissémination dans l'environnement, ODE) http://www.admin.ch/ch/f/rs/8/814.911.fr.pdf
Ordonnance du 25 août 1999 sur l'utilisation des organismes en milieu confiné (Ordonnance sur l'utilisation confinée, OUC) http://www.admin.ch/ch/f/rs/8/814.912.fr.pdf
Loi fédérale du 9 octobre 1992 sur les denrées alimentaires et les objets usuels (loi sur les denrées alimentaires, LDAI); RS 817.0 http://www.admin.ch/ch/f/rs/8/817.0.fr.pdf
Ordonnance du 1 er mars 1995 sur les denrées alimentaires (ODAI); RS 817.02 http://www.admin.ch/ch/f/rs/8/817.02.fr.pdf
Ordonnance du 26 juin 1995 sur les additifs admis dans les denrées alimentaires (O sur les additifs, OAdd); RS 817.021.22 http://www.admin.ch/ch/f/rs/8/817.021.22.fr.pdf
Ordonnance du 26 juin 1995 sur les substances étrangères et les composants dans les denrées alimentaires (O sur les substances étrangères et les composants, OSEC); RS 817.021.23 http://www.admin.ch/ch/f/rs/8/817.021.23.fr.pdf
Ordonnance du 19 novembre 1996 concernant la procédure d'autorisation relative aux denrées alimentaires OGM, aux additifs OGM et aux auxiliaires technologiques OGM (OAOGM); RS 817.021.35 http://www.admin.ch/ch/f/rs/8/817.021.35.fr.pdf
Ordonnance du 6 mars 2000 sur l'indication du pays de production des denrées alimentaires, des additifs alimentaires et des matières premières (Ordonnance sur l’indication de la provenance des matières de base, OIPMB); RS 817.021.51. http://www.admin.ch/ch/f/rs/8/817.021.51.fr.pdf
Ordonnance du 26 juin 1995 sur la valeur nutritive (ONutr); RS 817.021.55. http://www.admin.ch/ch/f/rs/8/817.021.55.fr.pdf
Ordonnance du 1er mars 1995 sur les objets usuels (OUs); RS 817.04 http://www.admin.ch/ch/f/rs/8/817.04.fr.pdf
Ordonnance du 26 juin 1995 sur les cosmétiques (OCos); RS 817.042.1 http://www.admin.ch/ch/f/rs/8/817.042.1.fr.pdf
Federal Senate - Modification of the Federal law on narcotics http://www.parlament.ch/ab/frameset/f/s/4611/45079/f_s_4611_45079_45107.htm
Federal Senate - Modification of the law on narcotics - products derived from narcotics http://www.parlament.ch/ab/frameset/f/s/4611/45079/f_s_4611_45079_45292.htm
National Council - debate on the initiative "La santé à un prix abordable" http://www.parlament.ch/ab/frameset/d/n/4605/24029/d_n_4605_24029_24149.htm
Productivity Commission 2001 - International Pharmaceutical Price Differences, Research Report, AusInfo, Canberra. - July 2001 - (225 pages) http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID277602_code010731670.pdf?abstractid=277602
Brazil, Pharmaceutical Industry and WTO - (87 pages) http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID272208_code010605140.pdf?abstractid=272208
Isadora Stehlin, Homeopathy: Real Medicine or Empty Promises? FDA Consumer magazine (December 1996). http://www.fda.gov/fdac/features/096_home.html
NCAHF - Position Paper on Homeopathy http://www.ncahf.org/pp/homeop.html
Price Supervisor, Echec du « deal » proposé par l’industrie pharmaceutique, Bern March 4, 1998. http://www.monsieur-prix.admin.ch/dynamic/cp/PHARMADEAL/F/PHARMADEAL.html
Price Supervisor, Le Surveillant des prix s’exprime sur le « deal » prévu par l’industrie pharmaceutique, February 4, 1998, http://www.monsieur-prix.admin.ch/dynamic/cp/GEPLANTER_PHARMADEAL/F/GEPLANTER_PHARMADEAL.html
Price Supervisor, Examen des prix des médicaments, Prise de position du Surveillant des prix, October 2, 1996 http://www.monsieur-prix.admin.ch/dynamic/cp/UBERPRUFUNG_MEDIPREISE/F/UBERPRUFUNG_MEDIPREISE.html
Price Supervisor, Annual Report 2000, DPC 5/2000, at 846 http://www.monsieur-prix.admin.ch/dynamic/rapport/00_JB/F/Rapport_annuel_2000.pdf
Price Supervisor, Annual Report 1998, DPC 1998/5, at 818. http://www.monsieur-prix.admin.ch/dynamic/rapport/98_JB/F/Rapport_annuel_1998.pdf
Price Supervisor, Annual Report 1997, DPC 1997/5 at 726-728. http://www.monsieur-prix.admin.ch/dynamic/rapport/97_JB/F/Rapport_annuel_1997.pdf
Price Supervisor, Annual Report 1996, at 108-111. http://www.monsieur-prix.admin.ch/dynamic/rapport/96_JB/F/Rapport_annuel_1996.pdf
Price Supervisor, Annual Report 1995, at 58-60. http://www.monsieur-prix.admin.ch/dynamic/rapport/95_JB/F/Rapport_annuel_1995.pdf
Price Supervisor, Annual Report 1993 (extract). http://www.monsieur-prix.admin.ch/dynamic/rapport/93_MEDIKAMENT/F/93-medi_f.pdf
Price Supervisor, Annual Report 1992 (extract). http://www.monsieur-prix.admin.ch/dynamic/rapport/92_MEDIKAMENT/F/92-medi_f.pdf
Price Supervisor, Annual Report 1991, (extract) http://www.monsieur-prix.admin.ch/dynamic/rapport/91_MEDIKAMENT/F/91-medi_f.pdf
Price Supervisor, Wettbewerbsmängel bei der Preisgestaltung der Medikamente in der Schweiz, Ein Beitrag zur Revitalisierung - Phase 2, Study of the Price Supervisor with the assistance of the Competition Commission (19 pages) http://www.monsieur-prix.admin.ch/dynamic/etude/STUDIE_MEDIKAMENTE/F/wettbewerb.pdf
Convention intercantonale du 3 juin 1971 sur le contrôle des médicaments http://www.admin.ch/ch/f/rs/c812_101.html
Ordonnance du 23 août 1989 concernant les produits immunobiologique http://www.admin.ch/ch/f/rs/8/812.111.fr.pdf
Loi fédérale du 3 octobre 1951 sur les stupéfiants et les substances psychotropes (Loi sur les stupéfiants, LStup http://www.admin.ch/ch/f/rs/8/812.121.fr.pdf
Ordonnance du 29 mai 1996 sur les stupéfiants et les substances psychotropes (Ordonnance sur les stupéfiants, Ostup) http://www.admin.ch/ch/f/rs/8/812.121.1.fr.pdf
Ordonnance de l'OFSP du 12 décembre 1996 sur les stupéfiants et les substances psychotropes (Ordonnance de l'OFSP sur les stupéfiants, Ostup-OFSP) http://www.admin.ch/ch/f/rs/8/812.121.2.fr.pdf
Ordonnance du 29 mai 1996 sur les précurseurs et autres produits chimiques utilisés pour la fabrication de stupéfiants et de substances psychotropes (Ordonnance sur les précurseurs, OPrec) http://www.admin.ch/ch/f/rs/8/812.121.3.fr.pdf
Ordonnance du 1er mars 1995 sur le tabac et les produits du tabac (O sur le tabac, OTab); RS 817.06 http://www.admin.ch/ch/f/rs/8/817.06.fr.pdf
Loi fédérale du 18 décembre 1970 sur la lutte contre les maladies transmissibles de l'homme (Loi sur les épidémies); RS 818.101 http://www.admin.ch/ch/f/rs/8/818.101.fr.pdf
Arrêté fédéral du 22 mars 1996 sur le contrôle du sang, des produits sanguins et des transplants; RS http://www.admin.ch/ch/f/rs/8/818.111.fr.pdf
ATF 127 IV 178 - Decision of the Swiss Federal Tribunal - regarding hallucinogen mushrooms - July 4, 2001 - http://www.eurospider.ch/buge3/index/127_IV.html
ATF 123 I 201 - Pharmacie Victoria SA and Joseph Ghaliounghi against Conseil d'Etat of the canton Geneva - June 24, 1997 http://www.eurospider.ch/buge3/index/123_I.html
ATF 125 I 474 - Decision of the Swiss Federal Tribunal - regarding MediService SA against Conseil d'Etat of the canton Vaud on mail order pharmacies - October 1, 1999 http://www.eurospider.ch/buge3/index/125_I.html
Rapport du Groupe de travail au Département de Justice et Police - Assistance au décès - March 1999 - (55 pages) http://www.ofj.admin.ch/themen/stgb-sterbehilfe/b-bericht-f.pdf
Rapport du Conseil Fédéral donnant suite au postulat Ruffy - Assistance au Décès - Adjonction au Code Pénal Suisse - (15 pages) http://www.ofj.admin.ch/themen/stgb-sterbehilfe/ber-ruffy-f.pdf
Members list of the Commission of judicial affairs of the Swiss National Council - CAJ-CN http://www.parlament.ch/afs/data/f/komm/f_komm_12.htm
Parliament member question on euthanasia http://www.parlament.ch/afs/data/f/gesch/2000/f_gesch_20001121.htm
Decision of the Swiss Federal Insurance Tribunal - Assura against Canton of Geneva - regarding reimbursement of hospital expenses - November 30, 2001 http://www.bger.ch
U.S. Federal Drug and Food Administration - FDA - home page http://www.fda.gov/guidance
Swiss Federal Administration - home page http://www.admin.ch
NIH Consensus Statement on Acupuncture (n° 107), http://odp.od.nih.gov/consensus/cons/107/107_statement.htm
FTC - Miracle health Claims, Add a Dose of Skeptici http://www.ftc.gov/bcp/conline/pubs/health/frdhea
National Center for Complementary and Alternative Medicine, Annual Report 2000 http://nccam.nih.gov/an/annual-report/nccam2000.pdf
Consensus Statement, Integration of Behavioral and Relaxation Approaches Into the Treatment of Chronic Pain and Insomnia, National Institutes of Health, http://text.nlm.nih.gov/nih/ta/www/17.html
Ordonnance du 26 juin 1996 sur le contrôle du sang, des produits sanguins et des transplants (Ordonnance sur le contrôle du sang); RS 818.111.3 http://www.admin.ch/ch/f/rs/8/818.111.3.fr.pdf
Ordonnance du 26 juin 1996 sur les essais cliniques de produits immunologiques; RS: 818.124. http://www.admin.ch/ch/f/rs/8/818.124.1.fr.pdf
Ordonnance du 13 janvier 1999 sur la déclaration des maladies transmissibles de l'homme (Ordonnance sur la déclaration); RS 818.141.1 http://www.admin.ch/ch/f/rs/8/818.141.1.fr.pdf
Ordonnance du 24 janvier 1996 sur les dispositifs médicaux (ODim); RS 819.124 http://www.admin.ch/ch/f/rs/8/819.124.fr.pdf
Loi fédérale du 18 mars 1994 sur l'assurance-maladie (LAMal); RS 832.10 http://www.admin.ch/ch/f/rs/8/832.10.fr.pdf
Ordonnance du 27 juin 1995 sur l'assurance-maladie (OAMal); RS 832.102 http://www.admin.ch/ch/f/rs/8/832.102.fr.pdf
Ordonnance du 29 septembre 1995 sur les prestations dans l'assurance obligatoire des soins en cas de maladie (O sur les prestations de l'assurance des soins, OPAS); RS 832.112.31 http://www.admin.ch/ch/f/rs/8/832.112.31.fr.pdf
Loi fédérale du 20 mars 1981 sur l'assurance-accidents (LAA); RS 832.20 http://www.admin.ch/ch/f/rs/8/832.20.fr.pdf
Ordonnance du 19 décembre 1983 sur la prévention des accidents et des maladies professionnelles (O sur la prévention des accidents, OPA); RS 832.30 http://www.admin.ch/ch/f/rs/8/832.30.fr.pdf
Constitution de l'Organisation mondiale de la santé du 22 juillet 1946; RS 0.810.1 http://www.admin.ch/ch/f/rs/i8/0.810.1.fr.pdf
Convention du 8 octobre 1970 pour la reconnaissance mutuelle des inspections concernant la fabrication des produits pharmaceutiques (avec notes explicatives); RS 0.812.101 http://www.admin.ch/ch/f/rs/i8/0.812.101.fr.pdf
Stability Testing of New Drug Substances and Products (Step 5) http://www.ifpma.org/pdfifpma/q1arstep4.pdf
Guideline on Photostability Testing (Step 5) http://www.ifpma.org/pdfifpma/q1b.pdf
Guideline on Stability Testing for New Dosage Forms Step 5 http://www.ifpma.org/pdfifpma/q1c.pdf
Guideline on Impurities in New Drug Substances (Revised Guideline) (Step 3) http://www.ifpma.org/word/Q3Arstep2.doc
Impurities in New Drug Products (Revised Guideline) (Step 3) http://www.ifpma.org/word/Q3Brstep2.doc
Q6B Guideline on Biotechnological Substances (Step 5) http://www.ifpma.org/pdfifpma/Q6bstep4.pdf
Q7A Guideline on Good Manufacturing Practices for Active Pharmaceutical Ingredients Step 5 http://www.ifpma.org/pdfifpma/Q7Astep4.PDF
Web site of the European Agency for the Evaluation of Medicinal Products (EMEA) http://www.emea.eu.int/#
EMEA Web Site for Human Medicines http://www.emea.eu.int/index/indexh1.htm
EMEA General Information for Sponsors of Orphan Medicinal Products (EMEA/4795/00) http://www.emea.eu.int/pdfs/human/comp/479500en.p
European Commission Enterprise DG http://pharmacos.eudra.org
European Commission, Enterprise Directorate-General, G10 Medicines High Level Group on Innovation and Provision of Medicines, Single market, implementation and legislation for consumer goods, Consultation Paper, p 20 http://pharmacos.eudra.org/F3/g10/docs/g10an1.pdf
Information on the high level group on Innovation and the Provision of Medicines http://pharmacos.eudra.org/F3/g10/p2.htm
Report from the Commission on the experience acquired as a result of the operation of the procedures for granting marketing
authorisations for medicinal products laid down in Regulation (EEC) N° 2309/93, 2001, (p 33)
http://pharmacos.eudra.org/F2/review/doc/reviewrapport/rap_fv_en.pdf
European Commission, Enterprise Directorate-General, Pharmaceutical Legislation Review 2001, Single market : management & legislation for consumer goods Pharmaceuticals : regulatory framework and market authorisations, (p 77) http://pharmacos.eudra.org/F2/review/doc/2codehumain_fr_18-7-2001.pdf
Reform of EU Pharmaceutical Legislation, Brussels, 18 July 2001, MEMO/01/267 http://pharmacos.eudra.org/F2/review/doc/brief_m01_267_en.pdf
List of directives and regulations of the European Union regarding proprietary medicinal products http://europa.eu.int/eur-lex/en/lif/reg/en_register_1530.html
Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products http://europa.eu.int/eur-lex/en/lif/dat/1965/en_3
Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products http://europa.eu.int/eur-lex/en/lif/dat/1975/en_3
Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products http://europa.eu.int/eur-lex/en/lif/dat/1975/en_3
Council Directive 78/25/EEC of 12 December 1977 on the approximation of the laws of the Member States relating to the colouring matters which may be added to medicinal products http://europa.eu.int/eur-lex/en/lif/dat/1978/en_3
Council Directive 89/342/EEC of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional provisions for immunological medicinal products consisting of vaccines, toxins or serums and allergens http://europa.eu.int/eur-lex/en/lif/dat/1989/en_3
Directive 2001/20/EC of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials http://europa.eu.int/eur-lex/en/lif/dat/2001/en_3
Commission Regulation (EC) No 2141/96 of 7 November 1996 concerning the examination of an application for the transfer of a marketing authorization for a medicinal product falling within the scope of Council Regulation (EC) No 2309/93 http://europa.eu.int/eur-lex/en/lif/dat/1996/en_3
Home Page of the Center for Drug Evaluation and Research (FDA) - home page http://www.fda.gov/cder/
List of Guidance Documents of CDER http://www.fda.gov/cder/guidance/index.htm
Center for Drug Evaluation and Research, 2000 Report to the Nation Improving Public Health Through Human Drugs - (46 pages) http://www.fda.gov/cder/reports/RTN2000/RTN2000.PDF
Center for Drug Evaluation and Research, CDER 1999 Report to the Nation Improving Public Health Through Human Drugs http://www.fda.gov/cder/reports/rtn99.pdf
CDER, 1997 Report to the Nation: Improving Public Health Through Human Drugs http://www.fda.gov/cder/reports/rptntn97.pdf
FDA Center for Food Safety and Applied Nutrition, Cosmetic Handbook http://www.cfsan.fda.gov/~dms/cos-hdbk.html
Home Page of the FDA Center for Food Safety & Applied Nutrition http://www.cfsan.fda.gov
Home Page of the FDA Center for Food Safety & Applied Nutrition regarding cosmetics http://vm.cfsan.fda.gov/~dms/cos-toc.html
Home Page in English of the Swiss Federal Administration http://www.admin.ch/ch/index.en.htm
Home Page in English of the Swiss Federal Parliament http://www.parlament.ch/poly/Framesets/E/Frame-E.
Home Page in English of the Swiss Federal Office of Public Health (FOPH) http://www.bag.admin.ch/e/index.htm
Swiss Federal Office for Public Health, Annual Report 2000 on biologic products http://www.bag.admin.ch/heilmitt/biologik/jahrb00
Swiss Federal Law on Therapeutic Products (English Translation); RS http://www.bag.admin.ch/heilmitt/gesetz/HMG_Engl.pdf
Swiss Department of Home Affairs, Rapport de consultation concernant les ordonnances sur les produits thérapeutiques Berne, 17 octobre 2001 http://www.bag.admin.ch/heilmitt/aktuell/f/vern_ber.pdf
Canton of Geneva, Dons d'organes - loi genevoise: du consentement explicite au consentement présumé http://www.geneve.ch/social/donsorg/welcome.html
Decision of the Swiss Federal Office for Justice, dated November 17, 1995, regarding the status of embryos http://www.vpb.admin.ch/franz/doc/60/60.67.html
Swiss Center for Technology Assessment - Anne Eckhard - Somatic gene therapy: Striking to the roots of disease http://www.ta-swiss.ch/www-support/reportlists/reports_temp/ta_32a_99_kurz_e.pdf
Loi fédérale sur les médicaments et les dispositifs médicaux (Loi sur les produits thérapeutiques - LPT - December 15, 2000 http://www.admin.ch/ch/f/ff/2000/5689.pdf
Form for the registration of manufacturers and devices In Vitro Diagnostic Medical Devices Directive, Article 10 http://www.bag.admin.ch/md/pdf/ivdform-fe.pdf
Form for the registration of information relating to certification of In Vitro Diagnostic Medical Devices (Annexes III to VII) - In Vitro Diagnostic Medical Devices Directive http://www.bag.admin.ch/md/pdf/ivdzert-fe.pdf
Normes techniques pour les dispositifs médicaux - Ordonnance sur les dispositifs médicaux (ODim) http://www.bag.admin.ch/md/pdf/normenf.pdf
Liste des numéros d’identification des organes responsables de l’évaluation de la conformité des dispositifs médicaux reconnus en Suisse (articles 8 et 11 ODim) July 3, 2001 http://www.bag.admin.ch/md/pdf/kbs-f.pdf
Notification according to art. 6 MDO - one notification for each device or group of devices. http://www.bag.admin.ch/md/pdf/me-formdfie.pdf
Dispositifs médicaux: annonce des incidents par les utilisateurs http://www.bag.admin.ch/md/pdf/vi_factf.pdf
World Intellectual Property Organization - home page http://www.wipo.org/
U.S. Federal Trade Commission - home page http://www.ftc.gov/
U.S. Department of Justice - home page http://www.usdoj.gov/
Etude prospective de mise en oeuvre du principe de transparence. Markus Spinatsch, Bundesverwaltung. Bericht zuhanden des Bundesamtes für Justiz, Bern, 25. Mai 2001 (study in German) http://www.ofj.admin.ch/themen/oeffprinzip/ber-bgoe-d.pdf
Department of Justice and Police, Pour une administration publique plus transparente, Projet de loi fédérale sur la transparence de
l’administration et rapport explicatif (69 pages)
http://www.ofj.admin.ch/themen/oeffprinzip/vn-ber-f.pdf
Draft - Loi fédérale sur la transparence dans l'administration - Ltrans http://www.ofj.admin.ch/themen/oeffprinzip/vn-ve-f.pdf
Commission d’experts du secret professionnel en matière de recherche médicale, Autorisation particulière de lever le secret professionnel à des fins de recherche dans les domaines de la médecine et de la santé publique, May 18, 2001, FF2001 5576-5583 http://www.admin.ch/ch/f/ff/2001/5576.pdf
Loi fédérale sur la protection des designs - Ldes http://www.admin.ch/ch/f/ff/2001/5487.pdf
Message du Conseil fédéral concernant l'initiative populaire pour des médicaments à moindre prix - May 12, 1999 - (25 pages) http://www.admin.ch/ch/f/ff/1999/6813.pdf
Accord entre la Communauté européenne et la Confédération suisse relatif à la reconnaissance mutuelle en matière d’évaluation de la conformité - FF 1999 5847 - (80 pages) http://www.europa.admin.ch/ba/off/abkommen/f/abf_tbt.pdf
Rapport du Conseil fédéral sur l’inventaire et l’évaluation des procédures de droit fédéral de l’économie (Réponse au Postulat David 96.3607 «Charges administratives») - February 17, 1999 - (181 pages, at 84, 101, 113, 172) http://www.admin.ch/ch/f/ff/1999/7603.pdf
Swiss Federal Council, Message concernant l’initiative populaire “pour des coûts hospitaliers moins élevés” - September 8, 1999 .- FF 1999 9005 - (pages 37) http://www.admin.ch/ch/f/ff/1999/9005.pdf
Swiss Parliament - National Council - debate on euthanasia - December 11, 2001 http://www.parlament.ch/ab/frameset/f/n/4611/44739/f_n_4611_44739_44740.htm
Swiss Parliament - National Council - debate on euthanasia - December 11, 2001 http://www.parlament.ch/ab/frameset/f/n/4611/44739/f_n_4611_44739_44842.htm
Federal Council, Message concernant la loi fédérale sur la protection contre les substances et les préparations dangereuses (Loi sur les produits chimiques, LChim) du 24 novembre 1999 - FF 2000 623 - (161 pages) http://www.admin.ch/ch/f/ff/2000/623.pdf
Swiss Federal Council, Message concernant l’initiative populaire "La santé à un prix abordable (initiative-santé)“ du 31 mai 2000 . FF 2000 3931 - (54 pages) http://www.admin.ch/ch/f/ff/2000/3931.pdf
Federal Council - Message relatif à l’initiative populaire «pour un approvisionnement en médicaments sûr et axé sur la promotion de la santé
(Initiative sur les médicaments)» du 1er mars 2000 - FF 200 1964- (16 pages)
http://www.admin.ch/ch/f/ff/2000/1964.pdf
Draft - Loi fédérale:sur les stupéfiants et les substances psychotropes (Loi sur les stupéfiants, LStup) - FF 2001 3631 - (pages 15) http://www.admin.ch/ch/f/ff/2001/3631.pdf
Message concernant la révision de la loi sur les stupéfiants du 9 mars 2001 - FF 2001 3537 - (94 pages) http://www.admin.ch/ch/f/ff/2001/3537.pdf
La situation en droit des cartels - Rapport à l’attention de la Commission de gestion du Conseil national du 11 octobre 2000 - FF 2001 3191 - (62 pages) http://www.admin.ch/ch/f/ff/2001/3191.pdf
Draft - Loi fédérale sur la protection contre les substances et les préparations dangereuses (Loi sur les produits chimiques, LChim) - FF 200 784 - (22 pages) http://www.admin.ch/ch/f/ff/2000/784.pdf
European Commission - XXIXth Report on Competition Policy 1999 - (pages 400) http://europa.eu.int/comm/competition/annual_reports/1999/en.pdf
Swiss Competition Commission - Accords sur les prix/répartition des ventes sur le marché des vitamines - DPC 2000/2 at 186-196. http://www.wettbewerbskommission.ch/site/f/dpc/dpc.Par.0004.Pic1.pdf
Decision of the Swiss Federal Tribunal of November 1, 2001 - 2P.67/2001 http://wwwsrv.bger.ch/cgi-bin/AZA/MapProcessorCGI_AZA?mapfile=pull/ConvertDocFrameCGI.map&ri=fr&lang=fr&ds=AZA_pull&d=01.11.2001_2P.67%2f2001&pa=2%7emelatonine%4010%7emelatonine%404%7e&
Decision of the Swiss Federal Tribunal of June 14, 2001, 6S.15/2001/vlc regarding marijuane and hachisch http://wwwsrv.bger.ch/cgi-bin/AZA/MapProcessorCGI_AZA?mapfile=pull/ConvertDocFrameCGI.map&ri=fr&lang=fr&ds=AZA_pull&d=14.06.2001_6S.15%2f2001&pa=2%7eoicm%4010%7eoicm%404%7e&
Decision of the Swiss Federal Tribunal - ATF 118 V 56 - January 30, 1992 - regarding admission of a pharmaceuticals to the reimbursement list http://www.eurospider.ch/buge3/index/118_V.html
Decision of the Swiss Federal Tribunal - ATF 120 II 248 - July 29, 1994 - regarding physicians' liability http://www.eurospider.ch/buge3/index/120_II.html
Decision of the Swiss Federal Tribunal - ATF120 V 76 -May 12, 1976 - regarding admission of a pharmaceuticals to the reimbursement list http://www.eurospider.ch/buge3/index/120_V.html
Decision of the Swiss Federal Tribunal - ATF 118 V 274 - December 4, 1992 - regarding reimbursement of a pharmaceuticals by a sickness insurance company http://www.eurospider.ch/buge3/index/118_V.html
Decision of the Swiss Federal Tribunal - ATF107 V 167 - June 4, 1981 - regarding reimbursement of a pharmaceutical by a sickness insurance company http://www.eurospider.ch/buge3/index/107_V.html
Decision of the Swiss Federal Tribunal - ATF124 III 375 - July 10, 1998 - regarding pharmaceuticals' certificate of complementary protection http://www.eurospider.ch/buge3/index/124_III.html
Decision of the Swiss Federal Tribunal - ATF 81 I 351 -October 26, 1955 - regarding fees for obtaining marketing authorizations http://www.eurospider.ch/buge3/index/81_I.html
Decision of the Swiss Federal Tribunal - ATF 109 V 197 - April 14, 1983 - regarding pharmaceuticals' admission to the reimbursement list http://www.eurospider.ch/buge3/index/109_V.html
Decision of the Swiss Federal Tribunal - ATF 120 V 481 - October 13, 1994 - regarding physicians' prescription of a pharmaceutical product http://www.eurospider.ch/buge3/index/120_V.html
Decision of the Swiss Federal Tribunal - ATF 105 V 186 - September 10, 1979 - regarding pharmaceuticals' admission to the reimbursement list http://www.eurospider.ch/buge3/index/105_V.html
WIPO, Parallel Imports in Pharmaceuticals: Implications for Competition and Prices in Developing Countries http://www.wipo.org/about-ip/en/studies/pdf/ssa_maskus_pi.pdf
WIPO, Rules of Arbitration http://arbiter.wipo.int/arbitration/arbitration-rules/complete.html
WIPO, Patent applications filed and patents granted during 1998 by country http://www.wipo.int/ipstats/en/publications/b/1998/i/pattab1.pdf
WIPO, Broad Summary of Patents figures - 1998 - http://www.wipo.int/ipstats/en/publications/b/1998/i/broad1.pdf
WIPO, Introduction to the Internaitonal phase of the PCT http://www.wipo.org/pct/guide/en/gdvol1/pdf/gdvol1.pdf
WIPO, Introduction to the national phase of the PCT http://www.wipo.org/pct/guide/en/gdvol2/pdf/gdvol2.pdf
WIPO, Rules of the Patent Cooperation Treaty - PCT http://www.wipo.org/pct/en/texts/articles/atoc.htm
WIPO, Regulations under the Patent Cooperation Treaty (PCT) http://www.wipo.org/pct/en/texts/pdf/pct_regs.pdf
WIPO, Administration instructions under the Patent Cooperation Treaty (PCT) - (89 pages) http://www.wipo.org/pct/en/texts/pdf/ai_01.pdf
Decision of the Geneva Administrative Tribunal - January 23, 2001 - regarding sale of unapproved medicines http://justice.geneve.ch/jurisprudence/pjdoc.tdb?L=14624
Decision of the Geneva Administrative Tribunal - August 23, 2000 - regarding sale of an unapproved medicine http://justice.geneve.ch/jurisprudence/pjdoc.tdb?L=14289
Decision of the Geneva Administrative Tribunal - March 23, 2000 - regarding sale of unapproved product http://justice.geneve.ch/jurisprudence/pjdoc.tdb?L=13140
Decision of the Geneva Administrative Tribunal - July 28, 1998 - regarding sale of product presented as homeopathic but containing active substances http://justice.geneve.ch/jurisprudence/pjdoc.tdb?L=12149
Geneva Law - Loi sur l’exercice des professions de la santé, les établissements médicaux et diverses entreprises du domaine médical -
K 3 05
http://www.geneve.ch/legislation/rsg/f/rsg_k3_05.html
Geneva Regulation on Health - Règlement d’exécution de la loi sur l’exercice des professions de la santé, les établissements médicaux et diverses entreprises du domaine médical - K 3 05.01 - July 25, 2001, in force since September 1, 2001 http://www.geneve.ch/legislation/rsg/f/rsg_k3_05p01.html
Judgment - CASE OF AGOUDIMOS AND CEFALLONIAN SKY SHIPPING CO. v. GREECE - June 28, 2001 - regarding advertisement against animal consumption and experiments http://www.echr.coe.int/Eng/Judgments.htm
The European Group on Ethics in Science and new Technologies - - Adoption of an Opinion on Ethical Aspects of Stem Cell Research and Use- January 2001 - (230 pages) http://www.europa.eu.int/comm/european_group_ethics/docs/dp15.pdf
The European Group on Ethics in Science and New Technologies to the European Commission - General Report on its activities 1998-2000 - (163 pages) http://www.europa.eu.int/comm/european_group_ethics/docs/rap_en.pdf
European Commission Directorate - General XII Science, Research and Development- Biotechnology R&D in Europe - 1996 - (37 pages) http://europa.eu.int/comm/research/biotech/national.pdf
European Commission, Directorate - General XII Science, Research Development - Coordination of Structural Biology in Europe, National EC and Industry Joint Efforts - (156 pages) http://europa.eu.int/comm/research/biotech/structur.pdf
COMMUNICATION FROM THE COMMISSION TOWARDS A STRATEGIC VISION OF LIFE SCIENCES AND BIOTECHNOLOGY:
CONSULTATION DOCUMENT - Brussels, September 4, 2001 - (32 pages)
http://europa.eu.int/comm/biotechnology/pdf/doc_en.pdf
European Parliament: Temporary Committee on Human Genetics and Other New Technologies in Modern Medicine - Report on the ethical, legal, economic and social implications of human genetics - November 8, 2001 - http://www.europarl.eu.int/comparl/tempcom/genetics/rapfin/rapfin_en.doc
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine (Convention on Human Rights and Biomedicine) (Oviedo Convention) - April 4, 1997 http://www.legal.coe.int/bioethics/gb/pdf/convention.pdf
Explanatory Report to the Convention for thze Protection of human rights and dignity of the human being with regard to the application of biology and medicine convention on human rights and biomedicines - 36 pages) http://www.legal.coe.int/bioethics/gb/pdf/rapport.pdf
Council of Europe - Recommendation 934 (1982) on genetic engineering http://stars.coe.fr/ta/ta82/erec934.htm
Council of Europe - Recommendation 1046 (1986) on the use of human embryos and foetuses for diagnostic, therapeutic, scientific, industrial and commercial purposes http://stars.coe.fr/ta/ta86/erec1046.htm
Council of Europe - RECOMMENDATION 1100 (1989)1 on the use of human embryos and foetuses in scientific research http://stars.coe.fr/ta/ta89/erec1100.htm
Council of Europe - Recommendation 1240 (1994) on the protection and patentability of material of human origin http://stars.coe.fr/ta/ta94/erec1240.htm
Council of Europe - Recommendation 1425 (1999) on Biotechnology and intellectual property http://stars.coe.fr/ta/ta99/erec1425.htm
Council of Europe - Recommendation 1512 (2001) on the Protection of the human genome by the Council of Europe http://stars.coe.fr/ta/TA01/EREC1512.htm
Council of Europe - Additional Protocol to the Oviedo Convention on the Prohibition of Cloning Human Beings and Explanatory report to the Protocol http://www.legal.coe.int/bioethics/gb/pdf/proto.pdf
IBC, International Bioethics Committee - Working Group on genetic data - Draft Report on Collection, Treatment, Storage and Use of Genetic Data - September 3, 2001 http://www.unesco.org/ibc/en/reports/DraftRep_UseOf_GenData_E.pdf
International Bioethics Committee (IBC)- The Use of Embryonic Stem Cells In Therapeutic Research - April 6, 2001 - (24 pages) http://www.unesco.org/ibc/en/reports/embryonic_ibc_report.pdf
Swiss Technology Assessment Center - Zentrum für Technologiefolgen-Abschätzung beim Schweizerischen Wissenschafts- und Technologierats- Technology Assessment Functional Food - July 2000 - (337 pages) http://www.ta-swiss.ch/www-remain/reports_archive/publications/2000/37_TA_Bericht_Functional_Food.pdf
Swiss Technology Assessment Center- Schweizerischen Wissenschafts- und Technologierat, Zentrum für Technologiefolgen-Abschätzung - Technologiefolgen-Abschätzung Zelluläre Xenotransplantation - March 2001 - (355 pages) http://www.ta-swiss.ch/www-remain/projects_archive/life_sciences/TA_39_2001_Bericht_Huesing.pdf
Center for Technology Assessment - Federal Office of Public Health - Swiss National Science Foundation - Transplantation Medicine
24 - 27. november 2000 at Bern - (52 pages)
http://www.ta-swiss.ch/www-remain/reports_archive/publications/2000/TA_P2_2000e.pdf
Swiss Technology Assessment - Citizen Panel Report - Genetic Technology and Nutrition: - 4 - 7 June 1999 in Berne - (52 pages) http://www.ta-swiss.ch/www-remain/reports_archive/publications/1999/ta_p_1_99_e.pdf
Medical Devices Ordinance (MDO) Information on Article 13 Reporting of serious incidents http://www.bag.admin.ch/md/pdf/VI-Indus-InfoE.pdf
Check list of documents required - Annonce d'investigations cliniques avec des dispositifs médicaux http://www.bag.admin.ch/md/pdf/kl-checklistdfie.pdf
European Committee for Standardization - CEN - home page http://www.cenorm.be/
Liste des tous les stupéfiants avec leurs numéros EAN-A, pharmacodes et leurs distributeurs -Appendice a /art. 1 OStup-OFSP- http://www.bag.admin.ch/betm/f/verz/verz_a.pdf
Liste des stupéfiants prohibés -Appendice d /art. 4 OStup-OFSP http://www.bag.admin.ch/betm/f/verz/verz_ad.pdf
Directives techniques sur le don de sang - http://www.bag.admin.ch/heilmitt/biologik/gesetze/f/nat_rlin.pdf
Le Conseil fédéral veut réglementer la recherche sur les cellules souches embryonnaires dans une loi fédérale spécifique - Press release - November 21, 2001 http://www.bag.admin.ch/dienste/medien/2001/f/01112137.htm
Commission d'experts du secret professionnel en matière de recherche médicale - Rapport d'activité pour les années 1998, 1999, 2000 - (25 pages) http://www.bag.admin.ch/themen/weitere/expkmedf/t_ber_f.pdf
Le Conseil fédéral met en vigueur les ordonnances relatives à la loi sur les produits thérapeutiques - Press release of October 17, 2001 http://www.bag.admin.ch/dienste/medien/2001/f/01101731.htm
Draft - New Swiss Federal law on patents - (Loi sur les brevets, LBI) http://www.ejpd.admin.ch/Doks/vl/patg_ges-f.pdf
Explicative report regarding the draft new Federal Law on patents - (93 pages) http://www.ejpd.admin.ch/Doks/vl/patg_ber-f.pdf
Annual report of the Federal Institute for Intellectual Property - (29 pages) http://www.ige.ch/F/institut/pdf/i102jb01f.pdf
Federal Department of Justice and Police - Biotechnologie et droit des brevets: Rapport sur la brevetabilité des inventions concernant les organismes - August 1993 - (52 pages) http://www.ige.ch/F/jurinfo/pdf/j140_biof.pdf
Council of Europe, Convention for the Protection of Human Rights and Fundamental Freedoms as amended by Protocol No. 11 with Protocol Nos. 1, 4, 6 and 7 http://www.echr.coe.int/Convention/webConvenENG.pdf
Council of Europe - Public Health page http://www.coe.fr/soc-sp/sante/default_eng.htm
Public Health Committee - Committee of experts on cosmetic products -"Indicative catalogue of criteria for delimiting borderline situations between cosmetic and medicinal products" http://www.coe.fr/soc-sp/sante/Cosm%20claims%20catalogue.htm
Council of Europe - Cosmétiques naturels - Notice of information to consumers http://www.coe.fr/soc-sp/sante/nat%20cosm.htm
List of medicines subject to prescription, 2000 edition http://www.coe.fr/soc-sp/sante/Alpha%20List%202000%20E.zip
Council of Europe - Committee of Ministers - Resolution AP(2000) on the classification of medicines which are obtainable only on medical prescription - March 15, 2000 http://cm.coe.int/ta/res/resAP/2000/2000xp1.htm
Council of Europe - Committee of Ministers . Resolution AP (99) 2- on warning phrases for certain categories of medicines http://www.coe.fr/cm/ta/res/resAP/1999/99xp2.htm
Council of Europe - Committee of Ministers - Resolution AP (96) - on the declaration of excipients present in pharmaceutical products - October 2, 1996 http://cm.coe.int/ta/res/1996/96xp1.html
Public Health Committee - Committe of experts on pharmaceutical questions - Note from the Austrian Delegation on the requirements applying to prescriptions - Medicines for human use except narcotics http://www.coe.fr/soc-sp/sante/97spt19reve.zip
Public Health Committe - Committee of experts on pharmaceutical questions - Final Report on Generic Medicines - April 2000 http://www.coe.fr/soc-sp/sante/CD-P-SPT%20(2000)%2027%20E%20-generic%20medicines.zip
Council of Europe - comparisons of regulations applying to vitamins http://www.coe.fr/soc-sp/sante/CD-P-SPT%20(98)%2024E%20-Vitamin%20products.zip
Public Health Committee - Committee of experts on pharmaceutical questions - Final Report on the importation of unregistered medicines - Multicountry comparisons - April 2000 http://www.coe.fr/soc-sp/sante/SPT28E%20-%20médicaments%20non%20enregistrés%20-%20Autriche.zip
Council of Europe's Policy Statements concerning nutrition, food safety and Consumer Health - Technical document - Guidelines concering scientific substantiation of health-related claims for functional food http://www.coe.fr/soc-sp/sante/functfood.ZIP
Council of Europe - Public Health Committee - Energy Drinks - Information Note to Consumers - May 2001 http://www.coe.fr/soc-sp/sante/energ_drinks.htm
FDA, Acupuncture needle status changed - April 1, 1996 http://www.fda.gov/bbs/topics/ANSWERS/ANS00722.html
FDA, Devices classification - previous correspondance http://www.fda.gov/cdrh/devadvice/21.html#contents
FDA - Product Code Classification Database http://www.fda.gov/cdrh/prodcode.html
FDA - Good Manufacturing Practices (GMP) / Quality System (QS) Regulation http://www.fda.gov/cdrh/devadvice/32.html#contents
FDA - CDRH Annual Report Fiscal Year 2000 http://www.fda.gov/cdrh/annual/fy2000/annualreport-2000.pdf
FDA - Breast Implants - An Information Update - 2000 - (82 pages) http://www.fda.gov/cdrh/breastimplants/indexbip.PDF
FDA - Investigation of Human Health Effects Associated with Potential Exposure to Genetically Modified CornJune 11, 2001 - (24 pages) http://www.cdc.gov/nceh/ehhe/Cry9cReport/cry9creport.pdf
FDA - FDA documents concerning StarLink http://www.epa.gov/scipoly/sap/index.htm#july
FDA - Food and Cosmetic Guidance Documents http://www.cfsan.fda.gov/~dms/guidance.html
FDA - Guidance for Industry - Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements http://www.cfsan.fda.gov/~dms/ssaguide.html
FDA - Draft - Guidance for Industry - Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using Bioengineering - January 2001 http://www.cfsan.fda.gov/~dms/biolabgu.html
FDA - Report on Consumer Focus Groups on Biotechnology http://www.cfsan.fda.gov/~comm/biorpt.html
FDA - Food and Cosmetics International Activities http://www.cfsan.fda.gov/~comm/intl-toc.html
FDA - A New Kind of Fish Story: The Coming of Biotech Animals - FDA Magazine - January February 2001 http://www.cfsan.fda.gov/~dms/fdbiofsh.html
FDA - Dietary supplements - home page http://www.cfsan.fda.gov/~dms/supplmnt.html
FDA - Overview of Dietary Supplements - FAQs http://www.cfsan.fda.gov/~dms/supplmnt.html
FDA - Claims That Can Be Made for Conventional Foods and Dietary Supplements http://www.cfsan.fda.gov/~dms/hclaims.html
FDA - A Food Labeling Guide--Appendix C http://www.cfsan.fda.gov/~dms/flg-6c.html
FDA - CFR 21 § 101.72 - Health claims: calcium and osteoporosis. http://www.cfsan.fda.gov/~lrd/cf101-72.html
FDA - Bovine Spongiform Encephalopathy (BSE) http://www.fda.gov/cber/bse/bse.htm
FDA - CBER Guidances / Guidelines / Points to Consider http://www.fda.gov/cber/guidelines.htm
FDA - CBER - Blood Publications http://www.fda.gov/cber/blood/bldpubs.htm
FDA - CBER - Tissue Related Documents http://www.fda.gov/cber/tissue/docs.htm
FOPH - Une vitamine B2 produite par génie génétique est autorisée - September 2001 http://www.bag.admin.ch/verbrau/aktuell/Medienmitteilungen/medienmitteilung_vit_b2_f.pdf
FOPH - Irradiation des denrées alimentaires http://www.bag.admin.ch/verbrau/lebensmi/infos/f/fakten/irradiation_denrees_alimentaires.pdf
FOPH - Aliments fonctionnels - Information page http://www.bag.admin.ch/verbrau/lebensmi/infos/f/fakten/aliments_fonctionnels.pdf
Draft - Ordinance on Foodstuffs (modification de l'ordonnance sur les denrées alimentaires) http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/revisionen/f/odal.pdf
Report regarding the proposed change to the ordinance on foodstuffs - (31 pages) http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/revisionen/f/commentaire_odal.pdf
Draft -Modifications of the ordinance on nutritive value http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/revisionen/f/onutr.pdf
Report on the proposed change of the ordinance on nutritive value http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/revisionen/f/commentaire_onutr.pdf
FOPH - Modification de l’ordonnance sur les denrées alimentaires (ODAl) - Analyse d'impact de la réglementation http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/revisionen/f/analyse_impact_odai.pdf
Séparation des OGM dans les filières des denrées alimentaires - Recherche effectuée sur mandat de l’Office fédéral de la santé publique http://www.bag.admin.ch/verbrau/lebensmi/gvo/f/prognos_kurzf.pdf
FOPH - Information on the label of GMO products http://www.bag.admin.ch/verbrau/lebensmi/gvo/f/prospectus.pdf
FOPH - Autorisation de mise sur le marché d'aliments spéciaux d'un genre nouveau - October 6, 1999 http://www.bag.admin.ch/dienste/medien/1999/f/99100635.htm
FOPH - Vitamines et sels minéraux dans les denrées alimentaires - mentions autorisées http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/f/vitamines_sels_mineraux_mentions.pdf
FOPH - Aide-mémoire pour l‘enregistrement de nouveaux produits http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/f/merkblatt_neuprodukten.htm
FOPH - Demande d'autorisation pour la mise sur le marché d'une denrée alimentaire http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/f/demande_autorisation_denree_alimentaire.pdf
Aide-mémoire pour l‘enregistrement des compléments alimentaires (food supplement) http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/f/merkblatt_nahrungsergaenzungen.htm
FOPH - Aide-mémoire pour l‘enregistrement des aliments de complément/aliments de supplément (ex. produits pour sportifs) http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/f/merkblatt_ergaenzungsnahrungen.htm
FOPH - list of autorizations granted for new food from July to December 2000 http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/d_f/2_sem_2000_bnl_aan.pdf
FOPH - Authorizations granted for special food - from July to December 2000 http://www.bag.admin.ch/verbrau/lebensmi/lmrecht/d_f/2_sem_2000_bs_aas.pdf
FOPH - Information letter n° 64 on borderline situations regarding cosmetic products - February 14, 2001 http://www.bag.admin.ch/verbrau/gebrauch/is/f/lettre_information_64.pdf
FOPH - Information no 8/97 - Indication du lot selon art. 23 al. 1 let. f Ous/Recommandation de la Commission de la concurrence au sens de l‘art. 45 de la Loi sur les cartels à l’adresse de l‘Office fédéral de la santé publique http://www.bag.admin.ch/verbrau/gebrauch/is/f/infoschreiben_8.htm
Liste des membres de la Commission fédérale de l'alimentation http://www.admin.ch/ch/f/cf/ko/index_50.html
Projet national « Santé et alimentation » - Ensemble pour une alimentation saine - October 24, 2001 http://www.bag.admin.ch/dienste/medien/2001/f/01102433.htm
Swiss Ethics Committee on Non-human Gene Technology - Rapport de la Commission fédérale d'éthique pour le génie génétique dans le domaine non humain - Evaluation éthique de la technologie «Terminator» http://www.buwal.ch/stobobio/ekah/pdf/term_f.pdf
FDA - Food Labeling; Health Claims and Label Statements for Dietary Supplements - Strategy for Implementation of Pearson Court Decision http://www.fda.gov/ohrms/dockets/98fr/120199b.pdf
Swiss Department of Home Affairs - Rapport de consultation concernant les ordonnances sur les produits thérapeutiques - October 17, 2001 - (18 pages) http://www.bag.admin.ch/heilmitt/aktuell/d/verordnungen/Rapport%20de%20consultation%20OPT%2017.10.01%20zum%20Druck-f.pdf
ATF 99 Ia 370 - decision of the Swiss Federal Tribunal regarding sale by Migro of Vitamins C http://www.eurospider.ch/buge3/index/99_I.html
ATF 127 II 91 - decision of the Swiss Federal Tribunal regarding an advertisement for milk as preventing osteoporose http://www.eurospider.ch/buge3/index/127_II.html
Special Programme for Research and Training in Tropical Diseases (TDR) - home page - "TDR focuses on neglected infectious diseases that disproportionally affect poor and marginalized populations" http://www.who.int/tdr/
United Nations Development Programme - home page - "UNDP provides funds; helps developing countries attract and use aid effectively" http://www.undp.org/
World Bank - home page - "one of the world's largest sources of development assistance. In Fiscal Year 2001, the institution provided more than US$17 billion in loans to its client countries" http://www.worldbank.org/
World Bank - Health, Nutrition, and Population Sector Strategy Paper - (93 pages) http://wbln0018.worldbank.org/HDNet/hddocs.nsf/c840b59b6982d2498525670c004def60/80ac87ad5b7910c4852568f20051bdcc/$FILE/hnp.pdf
FDA - Participation of Racial/Ethnic Groups in Clinical Trials and Race-Related Labeling: A Review of New Molecular Entities Approved 1995-1999 - http://www.fda.gov/cder/reports/race_ethnicity/race_ethnicity_report.htm
PERF - Pan European Regulatory Forum - home page - "The ultimate aim of this programme is the transposition of all technical regulations and European technical acts into the national legislation of central and eastern European countries (CEECs)" http://perf.eudra.org/
European Commission - Pharmaceuticals in the European Union - Information brochure - (42 pages) http://pharmacos.eudra.org/F2/pharmacos/docs/brochure/pharmaeu.pdf
European DG Enterprise - Inventory of Community and national incentive measures to aid the research, marketing, development and availability of orphan medicinal products - (17 pages) http://pharmacos.eudra.org/F2/orphanmp/doc/inventory/Inventory-en.pdf
Draft Guideline on the format and content of applications for designation as orphan medicinal products and on the transfer of designations from one sponsor to another, revision December 2000 http://pharmacos.eudra.org/F2/pharmacos/docs/Doc2000/dec/format-content-rev3.pdf
COMMISSION REGULATION (EC) No 847/2000 of 27 April 2000 laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts http://pharmacos.eudra.org/F2/orphanmp/doc/rev1/en1.pdf
REPORT on the communication from the Commission on the Single Market in Pharmaceuticals (COM(98)0588 - C4-0127/99) - April 21, 1999 - (18 pages) http://pharmacos.eudra.org/F2/smarket/pdf/cemaipen.pdf
Third Round Table "Completing the Single Pharmaceutical Market" - December 7, 1998, (77 pages) http://pharmacos.eudra.org/F2/smarket/pdf/Roundt3.pdf
Directive 2001/20/EC on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use http://www.europa.eu.int/eur-lex/en/lif/dat/2001/en_301L0020.html
European Commission, Provisions of a directive on traditional medicinal products http://www.mca.gov.uk/ourwork/licensingmeds/herbalmeds/echerb.pdf
The rules governing medicinal products in the European Union - Pharmaceutical legislation- Medicinal products for human use- Volume I -1998 - (294 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol1/vol1en.pdf
Notice to Applicants Volume 2A - Procedures for marketing autorisation http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol2/vol2aen.pdf
Notice to Applicants - Volume 2B - Medicinal products for human use - Presentation and content of the dossier - 1998 - (206 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol2/vol2ben.pdf
Guidelines - Volume 3A - Medicinal products for human use - Quality and biotechnology - 1998 - (417 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol3/vol3aen.pdf
Guidelines - Volume 3B - Medicinal products for human use - Safety, environment and information - 1998 - (240 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol3/Vol3ben.pdf
Guidelines - Volume 3C - Medicinal products for human use - Efficacy - 1998 - (402 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol3/Vol3cen.pdf
Volume 4 - Good manufacturing practices - Medicinal products for human and veterinary use - (153 pages) http://pharmacos.eudra.org/F2/eudralex/download/volpdf/vol4/vol4en.pdf
European Commission - Revision of Annex 14 to the EU Guide to Good Manufacturing Practice - Manufacture of medicinal products1 derived from human blood or human plasma - (7 pages) http://pharmacos.eudra.org/F2/eudralex/vol-4/pdfs-en/gmpan14_en.pdf
U.S. Department of Justice and the Federal Trade Commission - Antitrust Guidelines for the Licensing of Intellectual Property - April 1996 http://www.usdoj.gov/atr/public/guidelines/ipguide.htm
Department of Justice and Federal Trade Commission - Statements of antitrust enforcement policy in health care http://www.ftc.gov/reports/hlth3s.htm
FTC Antitrust Actions in health care services and products - June 2001 http://www.ftc.gov/bc/hcindex/hcupdate.pdf
FTC - Analysis to Aid Public Comment - proposed consent order with Hoechst Marion Roussel, Inc. (“HMR”), Carderm Capital, L.P.
(“Carderm”), and Andrx Corporation (“Andrx”) - (7 pages9
http://www.ftc.gov/os/2001/04/hoechstanalysis.pdf
FTC - Complaint - against Schering-Plough Corporation, Upsher-Smith Laboratories, American Home Products Corporation, http://www.ftc.gov/os/2001/04/scheringpart3cmp.pdf
FTC - Antitrust Guidelines for Collaborations Among Competitors - April 2000 - (39 pages) http://www.ftc.gov/os/2000/04/ftcdojguidelines.pdf
FTC - Marketer of Herbal Supplement Products Agrees to Settle FTC Charges That Safety and Health Benefit Claims Were False http://www.ftc.gov/opa/2001/12/chrisenterprises2.htm
FTC - Statement of the Federal Trade Commission's Bureau of Consumer Protection On the National Cancer Institute's Report on Cigarette Testing Method - November 27, 2001 http://www.ftc.gov/opa/2001/11/ncistudy.htm
The Directory of Federal and State Nutrition Monitoring and Related Research Activities Interagency Board for Nutrition Monitoring and Related Research- Nutrition Monitoring in the United States - April 2000 - (268 pages) http://www.cdc.gov/nchs/data/misc/direc-99.pdf
Healthy People 2010: Volume II (second edition) (664 pages) - Chapter 17 on Medical Product Safety - (20 chapters) http://www.health.gov/healthypeople/Document/pdf/Volume2/17Medical.pdf
National Cancer Institute. Health effects of exposure to environmental tobacco smoke: the report of the California Environmental Protection Agency. Smoking and tobacco control monograph no. 10. Bethesda - 1999 - (NIH publication no. 99-4645). http://rex.nci.nih.gov/NCI_MONOGRAPHS/MONO10/MONO10.HTM
ational Cancer Institute. Smokeless Tobacco or Health - Monograph no. 10. Bethesda - September 1992 - http://rex.nci.nih.gov/NCI_MONOGRAPHS/MONO2/MONO2.HTM
National Institutes of Health - Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control (February 1997) http://rex.nci.nih.gov/NCI_MONOGRAPHS/MONO8/MONO8.HTM
FTC - Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation - November 20, 2001 - news release http://www.ftc.gov/opa/2001/11/hearst.htm
FTC - Five Manufacturers of Over-the-Counter Analgesic Products Agree to Settle Charges of Mislabeling Certain Products as "Made in USA" - November 6, 2001 - press release http://www.ftc.gov/opa/2001/11/musa.htm
FTC -FTC Staff Comments on FDA’s Plans to Collect Information on Direct-To-Consumer Prescription Drug Advertising - September 24, 2001 - http://www.ftc.gov/be/v010008.htm
Dennis Murphy, Theodore H. Hoppock and Michelle K. Rusk - A Generic Copy Test of Food Health Claims in Advertising - November 1998 http://www.ftc.gov/os/1998/9811/netfood.pdf
Bureau of Economics with the Bureau of Competition and the Bureau of Consumer Protection - Competition and the Financial Impact of the Proposed Tobacco Industry Settlement - September 1997 http://www.ftc.gov/reports/tobacco/ndoc95.pdf
FTC - Dietary Supplements: An Advertising Guide for Industry - (32 pages) http://www.ftc.gov/bcp/conline/pubs/buspubs/dietsupp.pdf
FTC - Enforcement Policy Statement on Food Advertising - May 1994 http://www.ftc.gov/bcp/policystmt/ad-food.htm
FTC - List of documents on tobacco http://www.ftc.gov/bcp/menu-tobac.htm
U.S. Patent and Trademark Office - PCT Administrative Instructions - (85 pages) http://www.uspto.gov/web/offices/pac/dapps/pct/pctadmin.pdf
U.S. Patent and Trademark Office - Provisional patents information http://www.uspto.gov/web/offices/pac/provapp.htm
US Patent and Trademark Office - Manual of Patent Examining Procedure http://www.uspto.gov/web/offices/pac/mpep/mpep_e8_pdfs_zipped.zip
US Patent and Trademark Office - list of cases in alphabetical order http://www.uspto.gov/web/offices/com/sol/foia/bpai.htm
US Patent and Trademark Office - Changes to Implement 20-Year Patent Term and Provisional Applications - June 1995 http://www.uspto.gov/web/offices/com/doc/uruguay/20_year_term.html
Patent and Trademark Office Report on Recommendations from the April 1998 Conference on Database Protection and Access Issues - July 1998 http://www.uspto.gov/web/offices/dcom/olia/dbconf/dbase498.htm
United States Patent and Trademark Office - Eighteen-Month Publication of Patent Applications http://www.uspto.gov/web/offices/pac/pgpub.htm
U.S. Patent and Trademark Office - Fee Schedule http://www.uspto.gov/web/offices/ac/qs/ope/1999/fee20011001.htm
US Patent and Trademark Office - Patent Search http://www.uspto.gov/patft/index.html
Drug Enforcement Agency - Schedules of controlled substances http://www.usdoj.gov/dea/pubs/schedule.pdf
US Drug Enforcement Administration - DEA - Information about Ritalin / Methylphenidate http://www.usdoj.gov/dea/concern/abuse/chap4/stimula/methylph.htm
US Drug Enforcement Administration - DEA - Information about Anorectic Drugs http://www.usdoj.gov/dea/concern/abuse/chap4/stimula/anorecti.htm
US Department of Justice - Tobacco news http://www.usdoj.gov/civil/cases/tobacco/index.htm
Pontifical Academy for life - Declaration on the production and the scientific and therapeutic use of human embryonic stem cells http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_20000824_cellule-staminali_en.html
Pontifical Academy for life - statement on the so-called "morning-after pill" http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_20001031_pillola-giorno-dopo_en.html
Pontifical Academy for life - Reflections on Cloning http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_30091997_clon_en.html
Pontifical Academy for life - identity and Statute of Human Embryos http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_06041998_embrione_en.html
CBO - The Proposed Tobacco Settlement: Issues from a Federal Perspective, April 1998 http://www.cbo.gov/showdoc.cfm?index=407&sequence=0&from=1
GAO - Adverse Drug Events, The Magnitude of Health Risk Is Uncertain Because of Limited Incidence Data, GAO report, January 2000 http://www.gao.gov/archive/2000/he00053t.pdf
·GAO - Adverse Events: Surveillance Systems for Adverse Events and Medical Errors, February 2000, http://www.gao.gov/archive/2000/he00061t.pdf
GAO - Attention Disorder Drugs Few Incidents of Diversion or Abuse Identified by Schools, September 2001, http://www.gao.gov/new.items/d011011.pdf
GAO - Dietary Supplements: Uncertainties in Analyses Underlying FDA's Proposed Rule on Ephedrine Alkaloids, July 1999, http://www.gao.gov/archive/1999/h299090.pdf
GAO - Drug Abuse: Efforts Under Way to Determine Treatment Outcomes, February 2000 http://www.gao.gov/archive/2000/he00060t.pdf
GAO - Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women, January 2001 http://www.gao.gov/new.items/d01286r.pdf
GAO - Health Products for Seniors: Potential Harm From "Anti-Aging" Products, September 2001, http://www.gao.gov/new.items/d011139t.pdf
GAO - Human Fetal Tissue: Acquisition for Federally Funded Biomedical Research, October 2000, http://www.gao.gov/archive/2000/d010065r.pdf
GAO - Human Subjects Research: HHS Takes Steps to Strengthen Protections, But Concerns Remain, May 2001 http://www.gao.gov/new.items/d01775t.pdf
GAO - Mutual Recognition Agreement: Update on the Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Good Manufacturing Practice Regulatory Systems, August 1999 http://161.203.16.4/paprpdf2/162604.pdf
GAO - Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs, February 1999 http://161.203.16.4/paprpdf2/161744.pdf
GAO - NIH Clinical Trials: Various Factors Affect Patient Participation, October 1999 http://www.gao.gov/archive/1999/he99182.pdf
GAO - NIH Research: Improvements Needed in Monitoring Extramural Grants, May 2000 http://www.gao.gov/archive/2000/h100139.pdf
GAO - Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement, July 2001, http://www.gao.gov/new.items/d01754.pdf
GAO - ·Women's Health: NIH Has Increased Its Efforts to Include Women in Research, May 2000, http://www.gao.gov/archive/2000/he00096.pdf
GAO - Vaccine Injury Trust Fund: Revenue Exceeds Current Need for Paying Claims, March 2000, http://www.gao.gov/archive/2000/he00067.pdf
GAO - Prescription Drugs, Many Factors Affected FDA's Approval of Selected 'Pipeline' Drugs, August 2000, http://www.gao.gov/archive/2000/he00140.pdf
GAO - Prescription Drugs: Drug Company Programs Help Some People Who Lack Coverage, November 2000 http://www.gao.gov/new.items/d01137.pdf
GAO - Pediatric Drug Research: Substantial Increase in Studies of Drugs for Children, But Some Challenges Remain, May 2001, http://www.gao.gov/new.items/d01705t.pdf
Judgment of the Court (Fifth Chamber) of 30 November 1983 - against Leendert van Bennekom - Case 227/82 - Concept of "Medicinal products" http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 7 February 1984. Duphar BV - Case 238/82 - Health-care scheme - Compatibility with the Treaty of restrictions on access to certain medicinal preparations http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court (Fifth Chamber) of 21 March 1991 - against Jean-Marie Delattre -Case C-369/88. - Concepts of "disease" or "illness" and "medicinal product" http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 31 October 1974 - Centrafarm BV et Adriaan de Peijper v Sterling Drug Inc. - Case 15-74 - Reference for a preliminary ruling: Hoge Raad - Netherlands - Parallel patents. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 20 May 1976 - Adriaan de Peijper, Managing Director of Centrafarm BV - Case 104-75
Reference for a preliminary ruling: Kantongerecht Rotterdam - Netherlands.
http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 10 October 1978 - Centrafarm BV v American Home Products Corporation - Case 3/78- Reference for a preliminary ruling: Arrondissementsrechtbank Rotterdam - Netherlands.
Serenid - Seresta.
http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 14 July 1981 - Merck & Co. Inc. v Stephar BV and Petrus Stephanus Exler. - Case 187/80 - Reference for a preliminary ruling: Arrondissementsrechtbank Rotterdam - Netherlands. - Patents - Pharmaceutical products. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm
Judgment of the Court of 18 May 1989 - The Queen v Royal Pharmaceutical Society of Great Britain, ex parte Association of Pharmaceutical Importers and others - Parallel imports - - Trade-mark law - Joined cases 266 and 267/87. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 23 May 1978 - Hoffmann-La Roche & Co. AG v Centrafarm - Case 102/77 - Re-packaging of trade-marked goods. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 9 July 1985 - Pharmon BV v Hoechst AG. - Case 19/84 - Patents - Extent of protection - Exhaustion of patent rights where a compulsory licence has been granted in respect of a parallel patent. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 3 March 1988 - Allen and Hanburys Ltd v Generics (UK) Ltd. - Case 434/85 - Patents endorsed 'Licences of right' - Scope of protection - Compulsory licence under a patent. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 29 November 1983 - Roussel Laboratoria BV - Case 181/82 - Regulation of prices for imported medicines. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 9 June 1988 - Commission of the European Communities v Italian Republic - Case 56/87 - National rules governing the prices of pharmaceutical products. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 19 March 1991 - Commission of the European Communities v Kingdom of Belgium - Case C-249/88 - National legislation on the price of pharmaceutical products - System of programme contracts. http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court of 28 February 1984 - Commission of the European Communities v Federal Republic of Germany - http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court (Fifth Chamber) of 27 May 1986. Société coopérative - Cophalux v Minister for Health - Rules governing the importation and marketing of medicinal products - Joined cases 87 and 88/85 http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of the Court (Third Chamber) of 7 March 1989 - Heinz Schumacher v Hauptzollamt Frankfurt am Main-Ost - Case 215/87
Importation of medicinal preparations
http://curia.eu.int/common/recdoc/indexaz/en/c1.htm#266/87
Judgment of March 21, 1991 - against Monteil and Samanni - Case 60/89 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of 16/04/1991, Upjohn / Farzoo - Case 112/89 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of May 20, 1992 - Commission / Germany - Case 290/90 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of December 12, 1993 - Pierrel and others / Ministero della Sanità - Case 83/92 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of October 5, 1995 - The Queen / Licensing Authority of the Department of Health and Norgine, ex parte Scotia Pharmaceuticals - Case C-440/93 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court (Fifth Chamber) of 3 December 1998 - The Queen v The Licensing Authority established by the Medicines Act 1968 - Case C-368/96 - Marketing authorisation - Abridged procedure - Essentially similar products. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 22 June 1994 - IHT Internationale Heiztechnik GmbH -Case C-9/93 - Splitting of a trade mark as a result of a voluntary assignment - - Free movement of goods. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court (Fifth Chamber) of 1 July 1993 - Eurim-Pharm GmbH v Bundesgesundheitsamt. - Case C-207/91.
- Parallel imports of pharmaceutical products
http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 12 November 1996 - The Queen v The Medicines Control Agency - Case C-201/94 - Parallel imports - Direct effect of Directive 65/65/EEC - Marketing authorization. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 11 July 1996 - Eurim-Pharm Arzneimittel GmbH v Beiersdorf AG - Case C-71/94 - Repackaging of trade-marked products http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 11 July 1996 - MPA Pharma GmbH v Rhône-Poulenc Pharma GmbH - Case C-232/94- Repackaging of trade-marked products http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 27 October 1992 - Generics (UK) Ltd and Harris Pharmaceuticals Ltd v Smith Kline & French Laboratories Ltd - Case C-191/90 - Compulsory patent licences http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 5 December 1996 - Merck & Co. Inc. -Joined cases C-267/95 and C-268/95 - Parallel imports of unpatentable pharmaceuticals - Spain and Portugal - http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 9 July 1997 - Generics BV v Smith Kline & French Laboratories Ltd. - Case C-316/95- Patent - Registration of medicinal products - Infringement. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 28 April 1998 - Raymond Kohll v Union des caisses de maladie - Case C-158/96- Reimbursement of medical expenses incurred in another Member State http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 28 April 1998 - Raymond Kohll v Union des caisses de maladie - Case C-158/96- Reimbursement of medical expenses incurred in another Member State http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 28 April 1998 - Nicolas Decker v Caisse de maladie des employés privés- Case C-120/95 - Reimbursement of medical expenses incurred in another Member State http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court (Fifth Chamber) of 10 November 1994 - Lucien Ortscheit GmbH v Eurim-Pharm Arzneimittel GmbH.-Case C-320/93.
- Importation of medicines not agreed by the importing State - Prohibition of advertising
http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 8 April 1992 - Commission of the European Communities v Federal Republic of Germany -Case C-62/90 - Importation of medicinal products y private individuals - Limits. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 8 June 1993 - Commission of the European Communities v Kingdom of Belgium - Case C-373/92 - Obligation to carry out examinations which have already been performed in the Member State of origin. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court (Sixth Chamber) of 23 January 1997 - Biogen Inc. v Smithkline Beecham Biologicals SA - Supplementary protection certificate for medicinal products - Refusal by the holder of the marketing authorization- Case C-181/95 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court (First Chamber) of 15 May 1997 - Bioforce GmbH v Oberfinanzdirektion München - Case C-405/95 - Common customs tariff - Heading 3004 - Echinacea - Medicament. http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
Judgment of the Court of 20 November 2001 - Zino Davidoff SA v A & G Imports Ltd and Levi Strauss & Co - Exhaustion of the rights conferred by a trade mark - Joined cases C-414/99 to C-416/99 http://curia.eu.int/common/recdoc/indexaz/en/c2.htm
EEC Council: Regulation No 17: First Regulation implementing Articles 85 and 86 of the Treaty http://europa.eu.int/eur-lex/en/lif/dat/1962/en_362R0017.html
Regulation No 19/65/EEC of 2 March of the Council on application of Article 85 (3) of the Treaty to certain categories of agreements and concerted practices http://europa.eu.int/eur-lex/en/lif/dat/1965/en_365R0019.html
Regulation (EEC) No 2821/71 of the Council of 20 December 1971 on application of Article 85 (3) of the Treaty to categories of agreements, decisions and concerted practices http://europa.eu.int/eur-lex/en/lif/dat/1971/en_371R2821.html
Commission Regulation (EC) No 2790/1999 of 22 December 1999 on the application of Article 81(3) of the Treaty to categories of vertical agreements and concerted practices http://europa.eu.int/eur-lex/en/lif/dat/1999/en_399R2790.html
Commission Regulation (EC) No 2659/2000 of 29 November 2000 on the application of Article 81(3) of the Treaty to categories of research and development agreements (Text with EEA relevance) http://europa.eu.int/eur-lex/en/lif/dat/2000/en_300R2659.html
76/642/EEC: Commission Decision of 9 June 1976 relating to a proceeding under Article 86 of the Treaty establishing the European Economic Community (IV/29.020 - Vitamins) http://europa.eu.int/eur-lex/en/lif/dat/1976/en_376D0642.html
Community legislation in force on Foodstuffs http://europa.eu.int/eur-lex/en/lif/reg/en_register_133014.html
Community legislation in force on cosmetics http://europa.eu.int/eur-lex/en/lif/reg/en_register_133016.html
Community legislation in force on health protection http://europa.eu.int/eur-lex/en/lif/reg/en_register_1530.html
European initiatives for smoking prevention http://europa.eu.int/comm/health/ph/programmes/tobacco/index_en.htm
Proposal for a Directive of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to the advertising and sponsorship of tobacco products - May 30, 2001 http://europa.eu.int/comm/health/ph/programmes/tobacco/comm283_en.pdf
European Union information on the safety of blood http://europa.eu.int/comm/health/ph/others/safety_blood/index_en.htm
The Joint Research Centre - home page - "the European Union’s scientific and technical research laboratory" http://www.jrc.cec.eu.int/index.asp
A European Parliament vote against a ban on human cloning has cleared the way for EU investment in stem cell research over the next five years. http://europa.eu.int/comm/research/headlines.html#01
Innovation in Europe: Research and Results - Medicine and health http://europa.eu.int/comm/research/success/en/med/succ-med.html
Green Paper on the Review of Council Regulation (EEC) No 4064/89
(presented by the Commission) - December 11, 2001 - (59 pages)
http://europa.eu.int/comm/research/success/en/med/succ-med.html
Proposal for a Council Regulation amending Regulation No 19/65/EEC on the application of Article 85(3) of the Treaty to certain categories of agreements and concerted practices- September 30, 1998 http://www.europa.eu.int/comm/competition/antitrust/com1998546_en.pdf
Case No COMP/M. 1806 - Astra Zeneca / Novartis - Regulation EEC No 4064/89 - merger procedure - (139 pages) http://www.europa.eu.int/comm/competition/mergers/cases/decisions/m1806_en.pdf
Merger Procedure Abbott / BASF - Case No COMP/M.2312 -REGULATION (EEC) No 4064/89 http://www.europa.eu.int/comm/competition/mergers/cases/decisions/m2312_en.pdf
Merger Procedure Pfizer / Warner Lambert - Case No COMP/M.1878 - Regulation (EEC) No 4064/89 http://www.europa.eu.int/comm/competition/mergers/cases/decisions/m1878_en.pdf
Merger Procedure - Hoechst / Rhône Poulenc - Case No IV//M. 1378 - Regulation EEC n° 4064/89 (55 pages) http://www.europa.eu.int/comm/competition/mergers/cases/decisions/m1378_en.pdf
Merger Procedure - Bain / Hoechst-Date Behring - Case No IV/M.954 -Regulation (EEC) No 4064/89 http://www.europa.eu.int/comm/competition/mergers/cases/decisions/m954_en.pdf
European Patent Office - Annual Report 2000 - (80 pages) http://www.european-patent-office.org/epo/an_rep/2000/pdf/fulldoc.pdf
Fees under the European Patent Organisation - Rules relating to fees of 20 October 1977 as last amended by decision of the Administrative Council of the European Patent Organisation http://www.european-patent-office.org/epo/ca/e/28_06_01.htm
EPO boards of appeal decisions - monthly update http://www.european-patent-office.org/dg3/updates/index.htm
EPO Enlarged boards of appeal decisions http://www.european-patent-office.org/dg3/g_dec/index.htm
Decision of the Enlarged Board of Appeal regarding the application of Article 53(b) EPC to transgenic plant varieties http://www.european-patent-office.org/dg3/g_dec/pdf/g980001.pdf
Decision of the Enlarged Board of Appeal - December 18, 1992- State of prior art for chemical compositions http://www.european-patent-office.org/dg3/g_dec/pdf/g920001.pdf
Decision of the Enlarged Board of Appeal - EPO - December 5, 1984 - regarding patent on second medical use http://www.european-patent-office.org/dg3/g_dec/pdf/g830006.pdf
EPC - European Patent Convention - (511 pages) http://www3.european-patent-office.org/dwld/epc/epc_2000.pdf
Ancillary Regulations to the European Patent Convention http://www.european-patent-office.org/legal/anc_reg/e/index.htm
Case Law of the Boards of Appeal by themes http://www.european-patent-office.org/legal/case_law/e/index.htm
EPO - Guidelines for examination in the European Patent Office - (466 pages) http://www.european-patent-office.org/legal/gui_lines/pdf/gui_e_full.pdf
International Patent Classification http://classifications.wipo.int/fulltext/new_ipc/index.htm
Introductory Manual to the IPC (International Patent Classification http://www.wipo.int/classifications/en/index.html
WIPO - Patent Protection and Access to HIV / AIDS Phamaceuticals in Sub-Saharan Africa - (105 pages) http://www.wipo.int/about-ip/en/studies/pdf/iipi_hiv.pdf
WHO - Globalization and Access to Drugs - Perspectives on the WTO/TRIPS Agreement (111 pages) http://www.who.int/medicines/library/dap/who-dap-98-9-rev/who-dap-98-9rev.pdf
WHO - Globalization, Patents and Drugs: An Annotated Bibliography - 2001 - (64 pages) http://www.who.int/medicines/library/par/who-edm-par-2001-1/who-edm-par-2001-1.pdf
WHO - Health Reform and Drug Financing: Selected Topics - 1998 - (62 pages) http://www.who.int/medicines/library/dap/who-dap-98-3/who-dap-98-3.pdf
WHO - Global Strategy for Containment of Antimicrobial Resistance - 2001 - (105 pages) http://www.who.int/emc/amrpdfs/WHO_Global_Strategy_English.pdf
WHO - Model list of Essential Drugs - (14 pages) http://www.who.int/medicines/organization/par/edl/edl11.pdf
WHO - The definition and selection process for an EDL (essential drug list) - Technical Briefing Paper - 27 October 2000 http://www.who.int/medicines/organization/par/edl/infedltechbrief.htm
WHO - Herbal medicines - Assessment of safety and efficacy http://www.who.int/medicines/library/trm/medicinalplants/assessdocs.shtml
WHO - Acupuncture http://www.who.int/medicines/library/trm/acupuncture/acupdocs.shtml
WHO - Biotechnology and Food Safety - Report of a Joint FAO/WHO Consultation http://www.fao.org/WAICENT/faoinfo/economic/esn/biotech/tabconts.htm
Codex Alimentarius Commission - home page http://www.codexalimentarius.net/
WHO - Model Certificate of a Pharmaceutical Product http://www.who.int/medicines/organization/qsm/activities/drugregul/certification/modcert.html
WHO - Guidelines on the implementation of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce http://www.who.int/medicines/organization/qsm/activities/drugregul/certification/certifguide.html
WHO - Achieving balance in national opioids control policy -- Guidelines for assessment - 2000 - (45 pages) http://www.who.int/medicines/library/qsm/who-edm-qsm-2000-4/Balance%20in%20Nat%20Opioids%20Control%20Policy%20final.pdf
International Narcotics Control Board - home page http://www.incb.org/
WHO - Good Manufacturing Practices http://www.who.int/medicines/organization/qsm/activities/qualityassurance/gmp/gmpcover.html
International Conference on Harmonisation - ICH - home page http://www.ifpma.org/ich1.html
ICH - Harmonisation process http://www.ifpma.org/ich4.html
ICH - list of guidelines http://www.ifpma.org/ich5.html
WTO - Uruguay Round Final Act: full texts http://www.wto.org/english/docs_e/legal_e/final_e.htm
WTO - Council for Trade-Related Aspects of Intellectual Property Rights - Document prepared by the International Bureau of WIPO for the Meeting on Intellectual on Genetic Resources - An Overview http://docsonline.wto.org/_
WTO - THE RELATIONSHIP BETWEEN THE CONVENTION ON BIOLOGICAL DIVERSITY (CBD) AND THE AGREEMENT ON THE TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS (TRIPS); http://docsonline.wto.org/_
Convention unique sur les stupéfiants de 1961 - conclue à New York le 30 mars 1961 - Signée par la Suisse le 20 avril 1961 - RS 0.812.121.0 http://www.admin.ch/ch/f/rs/i8/0.812.121.0.fr.pdf
Protocole portant amendement de la Convention unique sur les stupéfiants de 1961 - Conclu à Genève le 25 mars 1972 - Approuvé par l’Assemblée fédérale le 21 mars 1995 - RS 0.812.121.01 http://www.admin.ch/ch/f/rs/i8/0.812.121.01.fr.pdf
Convention sur les substances psychotropes - Conclue à Vienne le 21 février 1971 - Entrée en vigueur pour la Suisse le 21 juillet 1996 - RS 0.812.121.02 http://www.admin.ch/ch/f/rs/i8/0.812.121.02.fr.pdf
Convention internationale de l’opium - Conclue à La Haye le 23 janvier 1912 -Entrée en vigueur pour la Suisse le 15 janvier 1925 - RS 0.812.121.2 http://www.admin.ch/ch/f/rs/i8/0.812.121.2.fr.pdf
Protocole amendant les accords, conventions et protocoles sur les stupéfiants - Entré en vigueur pour la Suisse le 25 septembre 1947 - RS 0.812.121.21 http://www.admin.ch/ch/f/rs/i8/0.812.121.21.fr.pdf
Protocole visant limiter et à réglementer la culture du pavot, ainsi que la production, le commerce international, le commerce de gros et l’emploi de l’opium - conclu à New York le 23 juin 1953 - RS 0.812.121.3 http://www.admin.ch/ch/f/rs/i8/0.812.121.3.fr.pdf
Convention internationale relative stupéfiants - conclue à Genève le 19 février 1925 - entrée en vigueur pour la Suisse le 2 juillet 1929 - RS 0.812.121.4 http://www.admin.ch/ch/f/rs/i8/0.812.121.4.fr.pdf
Convention pour limiter la fabrication et réglementer la distribution des stupéfiants - conclue à Genève le 13 juillet 1931 - entrée en vigueur pour la Suisse le 9 juillet 1933 - RS 0.812.121.5 http://www.admin.ch/ch/f/rs/i8/0.812.121.5.fr.pdf
Protocole du 19 novembre 1948 plaçant sous contrôle international certaines drogues non visées par la Convention du 13 juillet 1931 - entré en vigueur pour la Suisse le 18 mars 1953 - RS 0.812.121.52 http://www.admin.ch/ch/f/rs/i8/0.812.121.52.fr.pdf
Convention du 26 juin 1936 pour la répression du trafic illicite des drogues nuisibles - conclue à Genève, le 26 juin 1936 - entrée en vigueur pour la Suisse le 31 mars 1953 - RS 0.812.121.6 http://www.admin.ch/ch/f/rs/i8/0.812.121.6.fr.pdf
Convention contre le dopage - conclue à Strasbourg le 16 novembre 1989 - entrée en vigueur pour la Suisse le 1er janvier 1993 - RS 0.812.122.1 http://www.admin.ch/ch/f/rs/i8/0.812.122.1.fr.pdf
Accord européen relatif à l’échange de substances thérapeutiques d’origine humaine - conclu à Paris le 15 décembre 1958 - entré en vigueur pour la Suisse le 1er décembre 1965 - RS 0.812.161 http://www.admin.ch/ch/f/rs/i8/0.812.161.fr.pdf
Convention relative à l’élaboration d’une Pharmacopée Européenne - conclue à Strasbourg le 22 juillet 1964 - entrée en vigueur pour la Suisse le 8 mai 19742 - RS 0.812.21 http://www.admin.ch/ch/f/rs/i8/0.812.21.fr.pdf
United States Department of Agriculture (USDA) - Agricultural Biotechnology http://www.aphis.usda.gov/biotechnology/index.html
U.S. Environmental Protection Agency - EPA - home page http://www.epa.gov/
National Academy of Sciences - Transgenic Plants and World Agriculture - (46 pages) http://bob.nap.edu/html/transgenic/pdf/transgenic.pdf
OECD - Biotechnology and Food Safety - home page http://www1.oecd.org/subject/biotech/
OECD .- Ad Hoc Group on Food Safety - Overview of National Food Safety Systems and Activities - (12 pages) http://www1.oecd.org/subject/biotech/overview_nfssa.pdf
OECD - GM Food Safety : Facts, Uncertainties and Assessment - February March 2000 - Raporteur's summary - (11 pages) http://www1.oecd.org/subject/biotech/Rapporteureng.pdf
OECD - Working Party on Biotechnology - Health Policy Brief - Data Protection in Transborder Flows of Health Research Data - December 1999 - (33 pages) http://www.olis.oecd.org/olis/1999doc.nsf/8358a613ec4462afc12569fa005d1700/c9c84852a946479cc12568430057171b/$FILE/12E93887.ENG
OECD - The Economic Aspects of Biotechnologies related to Human Health Part I - 1998 - (72 pages) http://www1.oecd.org/dsti/sti/s_t/biotech/prod/health.pdf
OECD - Working Party on Biotechnology - Economic Aspects of Biotechnologies related to Human Health - 1998 - (269 pages) http://appli1.oecd.org/olis/1998doc.nsf/4cf568b5b90dad994125671b004bed59/f38277100c7a721bc12566b1006273a6/$FILE/11E88111.ENG
OECD - Food Safety and Quality -1999 - (82 pages) http://www1.oecd.org/subject/biotech/5199081e.pdf
OECD - Intellectual Property, Technology Transfer and Genetic Resources - an OECD Survey of current practices and policites - (81 pages) http://www1.oecd.org/dsti/sti/s_t/biotech/prod/ipr.pdf
OECD - home page http://www.oecd.org
OECD - Directorate for Science, Technology and Industry - Committee for Scienttific and Technological Policy - Working Party on Biotechnology - Consultation on Xenotransplantation Surveillance : Summary Report - (51 pages) http://www.olis.oecd.org/olis/2001doc.nsf/c5ce8ffa41835d64c125685d005300b0/7d4e7b2820d508dfc1256af1005328fc/$FILE/JT00115450.PDF
Règlement d’application de la loi sur l’université du 10 mars 1986 - C 1 30.01 http://www.geneve.ch/legislation/rsg/f/rsg_c1_30p01.html
Règlement de l’université du 7 septembre 1988 - C 1 30.06 http://www.geneve.ch/legislation/rsg/f/rsg_c1_30p06.html
OECD - Science Technology Industry - University Research in Transition - 1999 - (98 pages) http://www.oecd.org/pdf/M000014000/M00014817.pdf
OECD - Why Mice Matter: Novel Systems for the Study of Human Disease from Basic Research to Applications - 1998 - (68 pages) http://www.oecd.org/pdf/M000014000/M00014633.pdf
OECD - Technology Incubators: Nurturing Small Firms - 1997 - (129 pages) http://www.oecd.org/pdf/M000014000/M00014673.pdf
OECD - Patents and Innovation in the International Context - 1997 - (36 pages) http://www.oecd.org/pdf/M000014000/M00014675.pdf
OECD - The Evaluation of Scientific Research: Selected Experiences - 1997 - (112 pages) http://www.oecd.org/pdf/M000014000/M00014831.pdf
OECD - Fiscal Measures to Promote R&D and Innovation - 1996 - (94 pages) http://www.oecd.org/pdf/M000014000/M00014678.pdf
OECD - Directorate for Financial, Fiscal and Enterprise Affairs - Committee on Competition Law and Policy - Competition Policy and Intellectual Property Rights - September 1998 - DAFFE/CLP(98)18 - (458 pages) http://www1.oecd.org/daf/clp/roundtables/IPR-GD.PDF
Swiss Federal Council - Message sur la Convention sur les droits de l'Homme et la Biomédecine - (66 pages) http://www.ofj.admin.ch/themen/bioeth/bot-konvention-f.pdf
Swiss Federal Council - Message concernant la loi fédérale sur la transplantation d’organes, de tissus et de cellules - (227 pages) http://www.bag.admin.ch/transpla/gesetz/f/BOTSCHAFT_TxG_120901.pdf
Federal Council - Message regarding the law on therapeutic products - (108 pages) http://www.bag.admin.ch/heilmitt/gesetz/f/botsch02.pdf
Rapport en vue de la procédure de consultation relative à la Convention sur les droits de l’Homme et la biomédecine - Septembre 1998 - (41 pages) http://www.ofj.admin.ch/themen/bioeth/vn-ber-f.pdf
Council of Europe - CDBI - Projet de Protocole additionnel à la Convention sur les droits de l'Homme et la Biomédecine relatif à la transplantation d'organes et de tissus d'origine humaine et rapport explicatif - February 1999 - (30 pages) http://www.nfp46.ch/downloads/law/ceprottp99.pdf
Council of Europe - Convention for the protection of Human Rights and dignity of the human being with regard to the application of biology and medicine: Convention on Human Rights and Biomedicine http://conventions.coe.int/treaty/EN/WhatYouWant.asp?NT=164&CM=1&DF=22/03/01
Council of Europe - Projet de Protocole additionnel à la Convention sur les Droits de l'Homme et la Biomédecine,
relatif à la transplantation d'organes et de tissus d'origine humaine - (9 pages)
http://www.bag.admin.ch/transpla/inter/f/Draft_PROTOCOL_TRANSP_250701.pdf
Decision of the Swiss Federal Tribunal - December 10, 2001 - case n° K.81/98 - I. Kammer - regarding sickness insurance reimbursement http://www.bger.ch
WTO - CANADA – TERM OF PATENT PROTECTION - Arbitration under Article 21.3(c) of the Understanding on Rules and Procedures Governing the Settlement of Disputes - (19 pages) http://www.wto.org/english/tratop_e/dispu_e/170arb_e.pdf
WTO - Canada – PATENT PROTECTION OF PHARMACEUTICAL PRODUCTS - Arbitration under Article 21.3(c) of the Understanding on Rules and Procedures - Award of the Arbitrator James Bacchus -August 2000 - (21 pages) http://www.wto.org/english/tratop_e/dispu_e/114abr_e.pdf
WTO - Canada – Patent Protection of Pharmaceutical products - Complaint by the European Communities and their member States
Report of the panel - (March 2000) - (222 pages)
http://www.wto.org/english/tratop_e/dispu_e/7428d.pdf
WTO - Canada – Term of Patent Protection - Report of the Panel - May 2000 - (163 pages in two parts) http://www.wto.org/english/tratop_e/dispu_e/1391da.pdf http://www.wto.org/english/tratop_e/dispu_e/1391db.pdf
La situation en droit des cartels - Rapport à l’attention de la Commission de gestion du Conseil national - October 11, 2000 - (62 pages) http://www.admin.ch/ch/f/ff/2001/3191.pdf
Swiss Federal Council - Message relatif à la révision de la loi sur les cartels - (74 pages) http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/MESSAGE/Message_relatif_a_la_revision_de_la_loi_sur_les%20cartels.pdf
Proposed changes to the Swiss law on cartels http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/TEXTES_DE_LOI/Loi_sur_les_cartels.pdf
Summary of the comments received on the proposed new Swiss law on cartels - (23 pages) http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/INTRODUCTION/Consultation_F.pdf
René Rhinow - Gutachten über die Verfassungsmässigkeit der Einführung von direkten Sanktionen im Kartellgesetz zuhanden des Generalsekretariats des Eidgenössischen Volkswirtschaftsdepartements (EVD) - (44 pages) http://www.evd.admin.ch/dynamic/dm/LOI_SUR_LES_CARTELS/F/INTRODUCTION/Gutachten%20Kartellgesetzrevision_.pdf
OFEFP - Dissémination expérimentale de blé génétiquement modifié à Lindau (ZH) - Evaluation de l’essai à l’aide d’une grille de décision1 http://www.umwelt-schweiz.ch/imperia/md/content/buwalcontent/folder/01-11-20gentech/13.pdf
Verfügung - November 20, 2001 - betreffend das Gesuch der ETH Zürich, vertreten durch das Institut für Pflanzenwissenschaften, vom
04. Januar 2001 um Bewilligung eines Freisetzungsversuchs mit gentechnisch verändertem KP4-Weizen in Lindau (ZH).
http://www.umwelt-schweiz.ch/imperia/md/content/buwalcontent/folder/01-11-20gentech/9.pdf
Swiss Federal Veterinary Office - home page http://www.bvet.admin.ch/0_navigation-e/0_index-intern.html
The ARAMIS Information System for research and development projects in Switzerland - home page - "provide information to interested parties about research which is financed or carried out by the Federal Government" http://www.aramis-research.ch/e/index.html
Swiss Federal Office for Education and Science - home page http://www.admin.ch/bbw/
WTO, United States - Section 211 Omnibus Appropriations Act of 1998 - AB-2001-7 - Report of the Appellate Body http://docsonline.wto.org/DDFDocuments/t/wt/ds/176ABR.doc
U.S. Code of Federal Regulations CFR - Title 45 - Public Welfare - Part 46 - Protection of human subjects http://www.brown.edu/Administration/Research_Administration/OPRR/46index.html
Belmont Report - Ethical Principles and Guidelines for the Protection of Human Subjects of Research - April 18, 1979 http://ohrp.osophs.dhhs.gov/humansubjects/guidance/belmont.htm
Jeanne Clark et al., USPTO - Patent Pools: A Solution to the Problem of Access in Biotechnology Patents? - December 2000 - (17 pages) http://www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf
GAO Report - Prescription Drugs: Prices Available Through Discount Cards and From Other Sources - December 5, 2001 - (10 pages) http://www.gao.gov/new.items/d02280r.pdf
Center for Disease Control and Prevention - home page http://www.cdc.gov/
U.S. Surgeon General - home page http://www.surgeongeneral.gov/sgoffice.htm
U.S. Public Health Service, Report of the Surgeon General’s Conference on Children’s Mental Health: A National Action Agenda. Washington, DC: Department of Health and Human Services, 2000 - (57 pages) http://www.surgeongeneral.gov/cmh/cmhreport.pdf
U.S. Department of Health and Human Services. The Surgeon General’s call to action to prevent and decrease overweight and obesity - 2001 - (39 pages) http://www.surgeongeneral.gov/topics/obesity/calltoaction/CalltoAction.pdf
Treating Tobacco Use and Dependence, U.S. Department of Health and Human Services Public Health Service - June 2000 - (196 pages) http://www.surgeongeneral.gov/tobacco/treating_tobacco_use.pdf
U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention - 2000 - (474 pages) http://www.cdc.gov/tobacco/sgr/sgr_2000/FullReport.pdf
KPMG - translation of the Swiss law on cartels http://www.kpmg.ch/library/attachments/tbasic/Federal_Law_Cartels_SR251_0_2283528.pdf
Expert Panel on the Future of Food Biotechnology - Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in Canada - February 2001 - (261 pages) http://www.rsc.ca/foodbiotechnology/GMreportEN.pdf
Royal Commission on Genetic Modifications - the Report - New Zealand http://www.gmcommission.govt.nz/RCGM/rcgm_report.html
US Congress - The Best Pharmaceuticals for Children Act http://www.fda.gov/cder/pediatric/PL107-109.pdf
FDA- International Conference on Harmonization - Public Meeting - Transcripts - 10:30 a.m.- Thursday, January 17, 2002 http://www.fda.gov/cder/audiences/iact/meeting_transcript_011702.htm
GAO - Biomedical Research: HHS Direction Needed to Address Financial Conflicts of Interest - November 2001 - (46 pages) http://www.gao.gov/new.items/d0289.pdf
FDA News - home page - "premier provider of domestic and international regulatory, legislative and business news and information for executives in industries regulated by the" FDA http://www.fdanews.com/index.html
Office fédéral des assurances sociales - Analyse des effects de l’assurance-maladie Rapport de synthèse - December 2001 - (181 pages) http://www.bsv.admin.ch/aktuell/presse/2001/f/01121701_synthesebericht.pdf
OFAS - Information relative au nouveau système de formation des prix des médicaments - (6 pages) http://www.bsv.admin.ch/kv/aktuell/f/f_InfoMedi1.pdf
OFAS - Statistique de l’assurance-maladie 2000 - 2001 - (138 pages) http://www.bsv.admin.ch/statistik/details/f/kv00f.pdf
OFAS - Liste des Spécialités http://www.bsv.admin.ch/sl/liste/f/index.htm
The Swiss Conference of the Cantonal Ministers of Public Health - home page - "serves as a political coordination organ for the health ministers of the twenty-six cantons" http://www.sdk-cds.ch/en/praesentation-e.html
Communication from the European Communities and their Member States to the TRIPS Council - The Relationship Between the Provisions of the TRIPS Agreement and Access to Medicines - Brussels, 13 June 2001 - (5 pages) http://europa.eu.int/comm/trade/pdf/med_trips.pdf
The European Commission - DG Trade - Access to Medicines - Home page http://europa.eu.int/comm/trade/csc/med.htm
Compulsory Licensing under TRIPs and Data Exclusivity - (24 pages) http://europa.eu.int/comm/trade/pdf/med_lic.pdf
United Nations Economic Commission for Africa - Organization of African Unity - Africa and the Multilateral Trading System Doha and Beyond - An Issues Paper - (32 pages) http://www.uneca.org/eca_resources/Conference_Reports_and_Other_Documents/espd/2001/eca_oau/issue_paper.PDF
WIPO - Agenda for Development of the International Patent System - (15 pages) http://www.wipo.int/eng/document/govbody/wo_gb_ab/pdf/a36_14.pdf
CRS Issue Brief for Congress - Technology Transfer: Use of Federally Funded Research and Development -Congressional Research Service The Library of Congress- February 2002 - (18 page) http://www.cnie.org/nle/crsreports/science/st-9.pdf
World Bank - Global Prospects and the Developing Countries 2002 - (271 pages) http://www.worldbank.org/prospects/gep2002/gep2002complete.pdf
Commonwealth v. Lanigan, 419 Mass. 15 (1994) - Supreme Judicial Court of Massachusetts, Norfolk. - Argued Sept. 8, 1994. -Decided Nov. 18, 1994. http://commonwealthpolice.com/2001%20Textbook%20Cases/Commonwealth/CommL/Commonwealth%20v.%20Lanigan,%20419%20Mass.%2015%20(1994).pdf
Moore v. Regents of the University of California - 793 P.2d 479 (Cal. 1990) http://www.richmond.edu/~wolf/moore.htm
Diamond v. Chakrabarty, 447 U.S. 303 (1980) http://www.ipmall.fplc.edu/hosted_resources/jepson/unit3abcd/diamond2.htm
Rapport annuel 2001 de la Commission de la concurrence au Conseil fédéral selon l'art. 49 al. 2 Lcart - February 2002 - (20 pages) http://www.wettbewerbskommission.ch/site/f/medien/Medienmitteilungen.Par.0027.Pic3.pdf
ComCo - Droit et politique de la concurrence DPC 98/1 - (195 pages) http://www.wettbewerbskommission.ch/site/f/dpc/dpc.Par.0002.Pic0.pdf
ComCo - Droit et Politique de la Concurrence 98/2 - (192 pages) http://www.wettbewerbskommission.ch/site/f/dpc/dpc.Par.0002.Pic1.pdf
ComCo - Droit et Politique de la Concurrence 98/4 - (56 pages) http://www.wettbewerbskommission.ch/site/f/dpc/dpc.Par.0002.Pic3.pdf
ComCo - Droit et Politique de la Concurrence (DPC) 99/1 - (211 pages) http://www.wettbewerbskommission.ch/site/f/dpc/dpc.Par.0003.Pic0.pdf
Peter Drahos -Developing Countries and International Intellectual Property Standard-setting - Commission on Intellectual Property Rights
Study Paper 8 -February 2002 - (52 pages)
http://www.iprcommission.org/documents%5CDrahos%20study.pdf
Michael Blakeney - Access to Genetic Resources, Gene-based Inventions and Agriculture - Commission on Intellectual Property Rights - Study Paper 3b - February 2002 - (39 pages) http://www.iprcommission.org/documents%5CBlakeney%20study.pdf
CIPR - Commission on Intellectual Property Rights - home page - "The Commission has been set up by the British government to look at how intellectual property rights can work better for poor people and developing countries" http://www.iprcommission.org/index.asp
Rapport annuel du Surveillant des prix - 2001 - February 2002 - (52 pages) http://www.monsieur-prix.admin.ch/dynamic/rapport/01_JB/F/Microsoft%20Word%20-%20rapport%20annuel%202001.pdf
Swiss National Council - Session d'hiver 2000 - Quatrième séance - November 30, 2000 - Debate on the Law on Therapeutic Products http://www.parlament.ch/ab/frameset/d/n/4605/22311/d_n_4605_22311_22324.htm?DisplayTextOid=22325
Swiss Senate - Session d'hiver 2000 - Huitième séance - December 7, 2000 - Debate on the Law on Therapeutic Products http://www.parlament.ch/ab/frameset/d/s/4605/23400/d_s_4605_23400_23404.htm?DisplayTextOid=23405
Senate and National Council, Winter session, 13th session of Winter 2000, December 15, 2000 - Final vote http://www.parlament.ch/ab/frameset/d/s/4605/25104/d_s_4605_25104_25111.htm?DisplayTextOid=25112
Procédure de consultation relative aux ordonnances d’application afférentes à la loi sur les produits thérapeutiques (LPT) http://www.bag.admin.ch/heilmitt/gesetz/verord/f/orien.pdf
List of disagreement between the Swiss Senate and the Swiss National Council, http://www.bag.admin.ch/heilmitt/gesetz/verord/f/diff.pdf
Draft - Ordonnance sur les médicaments (ordonnance sur les médicaments, OMéd) http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vam.pdf
Rapport explicatif concernant l’ordonnance sur les médicaments OMéd - Project of September 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vam_erl.pdf
Draft - Ordonnance de l'ISPT sur les exigences relatives à l'autorisation de mise sur le marché des médicaments
(ordonnance sur les exigences relatives aux médicaments, OEMéd)
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/amzv.pdf
Draft - Ordonnance sur les autorisations dans le domaine des médicaments - OAMéd http://www.bag.admin.ch/heilmitt/gesetz/verord/f/ambv.pdf
Rapport explicatif concernant l’ordonnance sur les autorisations dans le domaine des médicaments - OAMéd - Project of September 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/ambv_erl.pdf
Draft - Ordonnance sur les dispositifs médicaux - Odim http://www.bag.admin.ch/heilmitt/gesetz/verord/f/mepv.pdf
U.S. National Institutes of Health (NIH), about NIH http://www.nih.gov/about/
FDA, Guidance for Institutional Review Boards and Clinical Investigators, 1998 Update http://www.fda.gov/oc/ohrt/irbs/default.htm
U.S. Department of Health and Human Services (HHS), home page http://www.hhs.gov/
NIH, List of bioethics resources on the web http://www.nih.gov/sigs/bioethics/international.html
OTA, Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues, September 1995, OTA-BP-H-163 http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9524/9524.PDF
Swiss National Council - Session de printemps 2000 - Sixième séance - 99.020, débat sur la Loi sur les produits thérapeutiques http://www.parlament.ch/ab/frameset/d/n/4602/9085/d_n_4602_9085_9204.htm
Swiss National Council - Session de printemps 2000 - Troisième séance - 08.03.00-08h35, Debate on the Law on Therapeutic products http://www.parlament.ch/ab/frameset/d/n/4602/8187/d_n_4602_8187_8363.htm
Swiss National Council - Session de printemps 2000 - Quatrième séance - 08.03.00-15h00, debate on the Law on Therapeutic products. http://www.parlament.ch/ab/frameset/d/n/4602/8533/d_n_4602_8533_8534.htm
Swiss Senate - Session d'automne 2000 - Septième séance - September 27, 2000 - Debate on the Law on Therapeutic products, http://www.parlament.ch/ab/frameset/d/s/4604/18863/d_s_4604_18863_18877.htm?DisplayTextOid=18878
Rapport explicatif concernant l’ordonnance sur les dispositifs médicaux - Odim - Project of September 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/mepv_erl.pdf
Draft - Ordonnance sur les émoluments de l’Institut suisse des produits thérapeutiques - OE ISPT http://www.bag.admin.ch/heilmitt/gesetz/verord/f/shi_gebv.pdf
Rapport explicatif concernant l’ordonnance sur les émoluments de l’Institut suisse des
produits thérapeutiques - OE ISPT - Project of September 2000
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/shi_gebv_erl.pdf
Procédure de consultation - Projets d’ordonnances sur les produits thérapeutiques (seconde tranche) http://www.bag.admin.ch/heilmitt/gesetz/verord/f/eroeffnung.pdf
Procédure de consultation sur les projets d’ordonnances sur les produits thérapeutiques: Nouvelle numérotation des articles de la loi sur les produits thérapeutiques: adaptation des renvois dans les ordonnances de la première tranche http://www.bag.admin.ch/heilmitt/gesetz/verord/f/artnum.pdf
Draft - Modification de l’ordonnance sur les médicaments http://www.bag.admin.ch/heilmitt/gesetz/verord/f/ergaenzungamv.pdf
Rapport explicatif concernant la modification de l’ordonnance sur les médicaments - OMéd - Project of December 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/ergaenzungamv_erl.pdf
Draft - Ordonnance sur l’abrogation et la modification du droit en vigueur du fait de la loi sur les
produits thérapeutiques§
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vaend.pdf
Rapport explicatif concernant l’ordonnance sur l’abrogation et la modification du droit en vigueur
du fait de la loi sur les produits thérapeutiques - Project of December 2000
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vaend_erl.pdf
Draft - Ordonnance sur la publicité pour les médicaments - OPMéd - http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vawerb.pdf
Rapport explicatif concernant l’ordonnance du Conseil fédéral sur la publicité pour les médicaments
Ordonnance sur la publicité pour les médicaments - OPMéd - Project of December 2000
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vawerb_erl.pdf
Draft - Ordonnance de l’Institut suisse des produits thérapeutiques sur l’autorisation simplifiée de médicaments http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vvza.pdf
Rapport explicatif concernant l’ordonnance de l’Institut suisse des produits thérapeutiques
sur l’autorisation simplifiée de médicaments - Project of December 2000
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vvza_erl.pdf
Draft - Ordonnance de l’Institut suisse des produits thérapeutiques sur la mise sur le marché des médicaments homéopathiques et des médicaments anthroposophiques sans indications http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vhom.pdf
Rapport explicatif concernant l’ordonnance de l’Institut suisse des produits thérapeutiques
sur la mise sur le marché des médicaments homéopathiques et des médicaments
anthroposophiques sans indications - Project of December 2000
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vhom_erl.pdf
Draft - Ordonnance sur les inspections dans le domaine des médicaments http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vinsp.pdf
Rapport explicatif concernant l’ordonnance sur les inspections dans le domaine des médicaments - Project of December 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vinsp_erl.pdf
Draft - Ordonnance sur les essais cliniques de produits thérapeutiques http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vklinver.pdf
Rapport explicatif concernant l’ordonnance sur les essais cliniques de médicaments - Project of December 2000 http://www.bag.admin.ch/heilmitt/gesetz/verord/f/vklinver_erl.pdf
Rapport explicatif concernant le projet de modification de - l’ordonnance du 29 mai 1996 sur les stupéfiants et les substances
psychotropes - Ostup - et de l' ordonnance sur les précurseurs - Opréc
http://www.bag.admin.ch/heilmitt/gesetz/verord/f/aendbetm_erl.pdf
Draft -Ordonnance sur les stupéfiants et les substances psychotropes http://www.bag.admin.ch/heilmitt/gesetz/verord/f/aendbetm.pdf
Draft - Ordonnance sur les précurseurs et autres produits chimiques utilisés pour la fabrication des stupéfiants et de substances psychotropes http://www.bag.admin.ch/heilmitt/gesetz/verord/f/aendvorlv.pdf
FDA - Mifepristone Information (home page) http://www.fda.gov/cder/drug/infopage/mifepristone/
FDA, CDER, New and Generic Drug Approvals: 1998-2001 http://www.fda.gov/cder/approval/index.htm
FDA, Electronic Orange Book - Approved Drug Products with Therapeutic Equivalence Evaluations (query page) http://www.fda.gov/cder/ob/default.htm
United States Patent and Trademark Office - US. PTO http://www.uspto.gov/
FDA, Warning Letters (home page) http://www.fda.gov/foi/warning.htm
The United States General Accounting Office - home page http://www.gao.gov/
European Patent Office - Guidelines for examination (400 pages) http://www.european-patent-office.org/legal/gui_lines/pdf/gui_e_full.pdf
Swiss Federal Institute of Intellectual Property - home page (in English) http://www.ige.ch/E/gisi.htm
Council for International Organizations of Medical Science ("CIOMS is an international, nongovernmental, non-profit-making organization established jointly by WHO and UNESCO in 1949.") http://www.cioms.ch/
World Trade Organization - home page http://www.wto.org/
Pharmaceutical Inspection Convention and Pharmaceutical Inspection Cooperation Scheme http://www.picscheme.org/index.htm
Complaint of the State of Montana v. Abbott - February 2002 - (45 pages) http://www.doj.state.mt.us/ago/newsrel/02releases/BSCComplaint.pdf
Complaint of the State of Nevada v. Abbott - January 2002 - (40 pages) http://ag.state.nv.us/agpress/2002/02_0117a.pdf
Agency for Healthcare Research and Quality (AHRQ) - home page http://www.ahcpr.gov/
Office of Inspector General (OIG) - Review of Pharmacy Acquisition Costs for Drugs Reimbursed Under the Medicaid Prescription Drug Program of the Montana Department of Public Health and Human Services - February 7, 2002 - (20 pages) http://oig.hhs.gov/oas/reports/region6/60100005.pdf
Speech of Thomas B. Leary - FTC - Antitrust Issues in the Settlement of Pharmaceutical Patent Disputes, Part II http://www.ftc.gov/speeches/leary/learypharmaceuticalsettlement.htm http://www.ftc.gov/speeches/leary/learypharma.htm
Complaint of the FTC Schering-Plough Corporation v. and American Home Products Corporation, http://www.ftc.gov/os/2001/04/scheringpart3cmp.pdf
FTC -Generic Drug Competition: Request for Public Comment on Proposed Commission Information Request to Firms In the Pharmaceutical Industry. - Agency Information Collection Activities; Proposed Collection; Comment Request - Federal Register Notice http://www.ftc.gov/os/2000/10/frngenericdrugstudy.htm
CBO - How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry - July 1998 http://www.cbo.gov/showdoc.cfm?index=655&sequence=0&from=1
FTC - Memorandum of law - of Amicus Curiae - in opposition to defendant's motion to dismiss -In re: Buspirone Patent Litigation - In re: Buspirone Antitrust Litigation - (37 pages) http://www.ftc.gov/os/2002/01/busparbrief.pdf

 

Back to main page

Back to authors selection

 

Last updated: July 7, 2002